Medizinische Universität Graz - Research portal

Navigation/Search

• Researchers.
  • Curriculum.
  • Publications.
  • Projects.
  • Presentations.
  • Advised theses.
• Institutions.
• Projects.
• Publications.
• Partners.
• Sponsors.
• Equipment.
• Knowhow.
• Fields of Research.

Khalil Michael |

Presentations at scientific and public conferences

Haindl, MT; Vershinin, V; Ferstl-Rohrbacher, A; Keck, T; Gugatschka, M; Wolfsberger, S; Khalil, M; Enzinger, C; Hochmeister, S Laboratory diagnostics of rhinoliquorrhea – re-evaluation of cut-off values of beta-trace protein
11th Congress of the European Academy of Neurology (EAN); June 21-24, 2025; Helsinki, FINLAND. 2025. [Oral Communication]
FullText

 

Hechenberger, S; Helmlinger, B; Jordan, S; Wurth, S; Heschl, B; Damulina, A; Eppinger, S; Khalil, M; Enzinger, C; Pinter, D Reliable Change Index for the self-administered, IPad-based processing speed test - the PST
MULT SCLER J. 2025; 31(1_SUPPL):
Web of Science

 

Helmlinger, B; Hechenberger, S; Hutter, J; Jordan, S; Wurth, S; Damulina, A; Heschl, B; Khalil, M; Enzinger, C; Pinter, D Distinct contribution of motor function and psychological factors on motor fatigue
MULT SCLER J. 2025; 31(1_SUPPL): P28
Web of Science

 

Khali, M Chimäre Antigenrezeptor-T-Zelltherapie in der Neuroimmunologie und Neuroonkologie - Die Rolle von Liquor- und Blut-Biomarkern bei der Beurteilung der Wirksamkeit und Sicherheit von CAR-T-Zelltherapien
ÖGN Jahrestagung 2025 - Gemeinsame Sitzung der AG Neuroimmunologie/ AG Neuro-Labordiagnostik/ AG NMO/ AG Neuroonkologie/AG Autoimmunencephalitis; MAR 11, 2025; Innsbruck, AUSTRIA. 2025. [Oral Communication]

 

Khalil, M Multiple Sklerose & Neuroimmunologie II – Therapie der Multiplen Sklerose Monitoring und Evaluation des Therapieerfolgs
ÖGN Jahrestagung 12.-14. März 2025; MAR 11-14, 2025; Innsbruck, AUSTRIA. 2025. [Oral Communication]

 

Khalil, M Entzündliche Erkrankungen des Nervensystems im Alter
2. ÖÄK-Diplomlehrgang 2025 in Graz; MAY 9, 2025; Graz, AUSTRIA. 2025. [Oral Communication]

 

Khalil, M Body fluid biomarkers: Specific markers for different tissue compartments?
MAGNIMS Workshop; APR 11, 2025; Graz, AUSTRIA. 2025. [Oral Communication]

 

Khalil, M Die Wertigkeit von Neurofilament-Leichtketten für den Einsatz in der klinischen Praxis
DGKN-Kongress 12. - 15. März 2025 Frankfurt am Main; MAR 12-15, 2025; Frankfurt, GERMANY. 2025. [Oral Communication]

 

Khalil, M Fluid biomarkers in CNS demyelinating disorders
7th Meet MS 2025; APR 11, 2025; Maribor, SLOVENIA. 2025. [Oral Communication]

 

Khalil, M Clinical implementation of Neurofilament Light 
Quanterix booth talk, AD/PD Vienna 2025; APR 1-5, 2025; Vienna, AUSTRIA. 2025. [Oral Communication]

 

Martinez-Serrat, M; Tafrali, C; Demjaha, R; Kaiser, T; Hofer, E; Ropele, S; Heschl, B; Wurth, S; Damulina, A; Pinter, D; Leppert, D; Benkert, P; Kuhle, J; Enzinger, C; Khalil, M Temporal Dynamics of Serum Neurofilament Light Chain in Multiple Sclerosis: A Retrospective Study in a Clinical Routine Setting
Österreichischen Gesellschaft für Neurologie – ÖGN; MÄR 12 - 14, 2025; Innsbruck. 2025. [Poster]

 

Martinez-Serrat, M; Tafrali, C; Demjaha, R; Kaiser, T; Hofer, E; Ropele, S; Heschl, B; Wurth, S; Damulina, A; Pinter, D; Leppert, D; Benkert, P; Kuhle, J; Enzinger, C; Khalil, M. Temporal Dynamics of Serum Neurofilament Light Chain in Multiple Sclerosis: A Retrospective Study in a Clinical Routine Setting
Deutsche Gesellschaft für Liquordiagnostik und Klinische Neurochemie e.V. - DGLN; MAI 16 - 17, 2025; Graz. 2025. [Poster]

 

Martinez-Serrat, M; Tafrali, C; Demjaha, R; Kaiser, T; Hofer, E; Ropele, S; Heschl, B; Wurth, S; Damulina, A; Pinter, D; Leppert, D; Benkert, P; Kuhle, J; Enzinger, C; Khalil, M. Temporal Dynamics of Serum Neurofilament Light Chain in Multiple Sclerosis: A Retrospective Study in a Clinical Routine Setting
European Academy of Neurology - EAN; JUN 21 - 25, 2025; Helsinki. 2025. [Oral Communication]

 

Tafrali, C; Martinez-Serrat, M; Demjaha, R.; Hechenberger, S; Helmlinger, B; Opriessnig, P; Pinter, D; Damulina, A; Wurth, S; Heschl, B; Leppert, D; Benkert, P; Kuhle, J; Ropele, S; Enzinger, C; Khalil, M, Choroid plexus volume and serum neurofilament light levels in relation to brain atrophy and lesion load in multiple sclerosis
DocDay; 13.02.2025; Medizinische Universität Graz. 2025. [Oral Communication]
FullText

 

Abdelhak, A; Maceski, AM; Schädelin, S; Willemse, E; Oechtering, J; Zadic, A; Gomez, JFV; Melie-Garcia, L; Cagol, A; Galbusera, R; Subramaniam, S; Lorscheider, J; Galli, E; Müller, J; Fischer-Barnicol, B; Achtnichts, L; Findling, O; Lalive, P; Bridel, C; Uginet, M; Müller, S; Pot, C; Mathias, A; Du Pasquier, R; Salmen, A; Hoepner, R; Chan, A; Disanto, G; Zecca, C; DSouza, M; Hemkens, L; Janiaud, PMC; Yaldizli, Ö; Derfuss, T; Roth, P; Gobbi, C; Tackenberg, B; Brassat, D; Oksenberg, JR; Wiendl, H; Berger, K; Hermesdorf, M; Piehl, F; Conen, D; Buser, A; Kappos, L; Khalil, M; Granziera, C; Leppert, D; Benkert, P; Kuhle, J Treatment-associated changes in serum glial fibrillary acidic protein and neurofilament light chain levels and risk of disability progression independent of relapse activity in multiple sclerosis
MULT SCLER J. 2024; 30(3):1138-1140.-40th ECTRIMS Congress; SEP 18-20, 2024; Copenhagen, DENMARK. [Oral Communication]
Web of Science

 

Angiari, S; Carlucci, T; Budui, SL; Bach, SD; Dusi, S; Walter, J; Ellmeier, E; Schnabl, A; Tafrali, C; Demjaha, R; Khalil, M; Bordag, N; Laudanna, C; Rossi, B; Constantin, C. Coenzyme A fueling with pantethine limits autoreactive T cell pathogenicity in experimental neuroinflammation
Harald von Boehmer Midwinter Conference 2024 “Advances in Immunobiology”; January 20-24, 2024; Seefeld in Tirol, AUSTRIA. 2024. [Oral Communication]

 

Angiari, S; Carlucci, T; Budui, SL; Bach, SD; Dusi, S; Walter, J; Ellmeier, E; Schnabl, A; Tafrali, C; Demjaha, R; Khalil, M; Bordag, N; Laudanna, C; Rossi, B; Constantin, G. Coenzyme A fueling with pantethine limits autoreactive T cell pathogenicity in experimental neuroinflammation
Gordon Research Conference on Immunometabolism in Health and Disease; June 16-21, 2024; Bryant University, Smithfield, Rhode Island (USA). 2024. [Poster]

 

Bsteh, G; Velez-Escola, L; Hegen, H; Khalil, M; Lindner, E; Schneider, S; Traxler, G; Raithel, E; Bsteh, C; Mitsch, C; Berger, T; Pemp, B Application of optical coherence tomography in multiple sclerosis - consensus recommendations of the Austrian network (AN-OCT-MS)
MULT SCLER J. 2024; 30(3):944-945.-40th ECTRIMS Congress; SEP 18-20, 2024; Copenhagen, DENMARK. [Oral Communication]
Web of Science

 

Demjaha, R; Hechenberger, S; Buchmann, A; Helmlinger, B; Heschl, B; Wurth, S; Opriessnig, P; Ropele, S; Leppert, D; Benkert, P; Kuhle, J; Enzinger, C; Pinter, D; Khalil, M Serum NfL levels and cognitive performance in persons with multiple sclerosis.
CSF Society Meeting; JUN 27-28, 2024; Barcelona, SPAIN. 2024. [Poster]

 

Demjaha, R; Seiler, S; Hofer, E; Tafrali, C; Pirpamer, L; Opriessnig, P; Ropele, S; Pinter, D; Hechenberger, S; Helmlinger, B; Leppert, D; Benkert, P; Kuhle, J; Enzinger, C; Schmidt, R; Khalil, M Age-Related Dynamics of Glial Fibrillary Acidic Protein Blood Levels in a Normal Ageing Cohort: Implications for Biomarker Studies in Neurological Diseases
MULT SCLER J. 2024; 30(3):583-584.-40th ECTRIMS Congress; SEP 18-20, 2024; Copenhagen, DENMARK. [Poster]
Web of Science

 

Ellmeier, E; Carlucci, T; Budui, SL; Bach, SD; Dusi, S; Walter, J; Schnabl, A; Stracke, A; Tafrali, C; Demjaha, R; Khalil, M; Bordag, N; Angelini, G; Calore, A; Bani, A; Terrabuio, E; Zenaro, E; Laudanna, C; Rossi, B; Constantin, C; Angiari, S Coenzyme A fueling with pantethine limits autoreactive T cell pathogenicity in experimental neuroinflammation
BraYn Conference 2024; October 9-11, 2024; Verona (Italy). 2024. [Oral Communication]

 

Ellmeier, E; Carlucci, T; Budui, SL; Bach, SD; Dusi, S; Walter, J; Schnabl, A; Tafrali, C; Demjaha, R; Khalil, M; Bordag, N; Angelini, G; Terrabuio, E; Zenaro, E; Laudanna, C; Rossi, B; Constantin, G; Angiari, S Coenzyme A fueling with pantethine limits autoreactive T cell pathogenicity in experimental neuroinflammation
EUR J IMMUNOL. 2024; 54: 401-401.-7th European Conference of Immunology; SEP 01-04, 2024; Dublin, IRELAND. [Oral Communication]
Web of Science

 

Gattermeyer-Kell, L; Khalil, M; Opriessnig, P; Kern, D; Franthal, S; Kögl, M; Katschnig-Winter, P; Schmidt, R; Enzinger, C; Schwingenschuh, P sGFAP – a potential biomarker for disease activity in essential tremor?
Jahrestagung der Österreichischen Gesellschaft für Neurologie 2024; MAR 13-15, 2024; Vienna, AUSTRIA. 2024. [Poster]

 

Hechenberger, S; Broeders, T; Bet, M; Helmlinger, B; Tinauer, C; Ropele, S; Heschl, B; Wurth, S; Damulina, A; Eppinger, S; Demjaha, R; Khalil, M; Schoonheim, M; Enzinger, C; Pinter, D Dynamic Brain Functional Connectivity Patterns associated with Fatigue in Multiple Sclerosis
MULT SCLER J. 2024; 30(3): 532-533. [Poster]
Web of Science

 

Hechenberger, S; Helmlinger, B; Jordan, S; Wurth, S; Heschl, B; Damulina, A; Eppinger, S; Khalil, M; Enzinger, C; Pinter, D Reliable Change Index for the self-administered, IPad-based processing speed test – the PST
The 10th Annual Meeting of the International MS Cognition Society (IMSCOGS), publication in MSJ. 2024; -The 10th Annual Meeting of the International MS Cognition Society; SEPT 2-3,2024; Bern, SWITZERLAND. [Poster]

 

Helmlinger, B; Hechenberger, S; Hutter, J; Jordan, S; Wurth, S; Damulina, A; Heschl, B; Khalil, M; Enzinger, C; Pinter, D Distinct contribution of motor function and psychological factors on motor fatigue
The 10th Annual Meeting of the International MS Cognition Society. 2024; MSJ 2024: -The 10th Annual Meeting of the International MS Cognition Society (IMSCOGS); SEPT 2-3, 2024; Bern, SWITZERLAND. [Poster]

 

Helmlinger, B; Seebacher, B; Opriessnig, P; Hechenberger, S; Ropele, S; Heschl, B; Ehling, R; Reindl, M; Khalil, M; Deisenhammer, F; Brenneis, C; Enzinger, C; Pinter, D Changes in White Matter Integrity after Gait Training in People with Multiple Sclerosis
MULT SCLER J. 2024; 30(3): 253-254. [Poster]
Web of Science

 

Khali, M Blutbasierte Biomarker und Gehirnalterung
ÖGN Jahrstagung 2024 - Gemeinsame Sitzung der AG Neuroimmunologie/ AG Neuro-Labordiagnostik/ AG NMO/ AG Neuroonkologie/AG Autoimmunencephalitis ; MAR 12, 2024; Vienna, AUSTRIA. 2024. [Oral Communication]

 

Khalil, M Update: Biomarker in der MS – what’s New?
Obtersteirische MS Gespräche; APR 18, 2024; Bruck, AUSTRIA. 2024. [Oral Communication]

 

Khalil, M Update Liquor- und Blutbiomarker zur Diagnose und Prognose bei MS
MS AKADEMIE der ÖGN; OCT 11-12, 2024; Mondsee, AUSTRIA. 2024. [Oral Communication]

 

Khalil, M Update Biomarker & Bildgebung
Highlights EXTRIMS 2024; SEP 9, 2024; Vienna, AUSTRIA. 2024. [Oral Communication]

 

Khalil, M Status Quo: Biomarker: Gestern und Heute und die prognostischen Ideen für die Zukunft
MS in motion; MAY 4, 2024; Vienna, AUSTRIA. 2024. [Oral Communication]

 

Khalil, M Entzündliche Erkrankungen des Nervensystems im Alter
1. ÖÄK-Diplom Geriatrie; JAN 19, 2024; Graz, AUSTRIA. 2024. [Oral Communication]

 

Khalil, M Die verfügbaren Prognosefaktoren zum wahrscheinlichen Verlauf einer MS sind genügend genau, um einen personalisierten „Treat-to-target“-Ansatz zu erlauben - CONTRA
3-Länder Experten Meeting MS; NOV 22-23, 2024; Zürs / Küsnacht, Switzerland. 2024. [Oral Communication]

 

Khalil, M NfL als Biomarker bei neurologischen Erkrankungen - allgemein und bei MS
ÖGN Fortbildung; MAY 22, 2025; Vienna, AUSTRIA. 2024. [Oral Communication]

 

Khalil, M Molekulare Demenz-Diagnostik
21. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR 13-15, 2024; Vienna, AUSTRIA. 2024. [Oral Communication]

 

Khalil, M Designing / performing multi-centre fluid biomarker studies
2nd ECTRIMS Winter School; JAN 17-19, 2024; Innsbruck, AUSTRIA. 2024. [Oral Communication]

 

Lukas Gattermeyer-Kell, Michael Khalil, Daniela Kern, Sebastian Franthal, Petra Katschnig-Winter, Mariella Kögl, Rina Demjaha, Cansu Tafrali, Edith Hofer, Reinhold Schmidt, Christian Enzinger, Petra Schwingenschuh Serum GFAP is elevated in early-stage late-onset essential tremor and associated to tremor progression
Jahrestagung der Österreichischen Parkinson-Gesellschaft; NOV 20-22, 2024; Vienna, AUSTRIA. 2024. [Oral Communication]

 

Lukas Gattermeyer-Kell, Michael Khalil, Peter Opriessnig, Daniela Kern, Sebastian Franthal, Mariella Kögl, Petra Katschnig-Winter, Reinhold Schmidt, Christian Enzinger, Petra Schwingenschuh sGFAP – a possible hint for cerebellar neurodegeneration in essential tremor?
Special Issue: Abstracts of the 10th Congress of the European Academy of Neurology, Helsinki, Finland. Eur J Neurol. 2024 Jun;31 Suppl 1(Suppl 1):e16337. doi: 10.1111/ene.16337. PMID: 38941135; PMCID: PMC11235658.. 2024; -10th EAN Congress; JUN 29 - JUL 2, 2024; Helsinki, FINLAND. [Oral Communication]

 

Lukas Gattermeyer-Kell, Michael Khalil, Peter Opriessnig, Daniela Kern, Sebastian Franthal, Mariella Kögl, Petra Katschnig-Winter, Reinhold Schmidt, Christian Enzinger, Petra Schwingenschuh sGFAP – a potential biomarker for disease activity in essential tremor?
Special Issue: Abstracts of the 10th Congress of the European Academy of Neurology, Helsinki, Finland. Eur J Neurol. 2024 Jun;31 Suppl 1(Suppl 1):e16337. doi: 10.1111/ene.16337. PMID: 38941135; PMCID: PMC11235658.. 2024; -10th EAN Congress; JUN 29 - JUL 02, 2024; Helsinki, FINLAND. [Oral Communication]

 

Maceski, AM; Benkert, P; Oechtering, J; Schädelin, S; Zadic, A; Gomez, JFV; Melie-Garcia, L; Cagol, A; Galbusera, R; Subramaniam, S; Lorscheider, J; Fischer-Barnicol, B; Achtnichts, L; Findling, O; Lalive, P; Uginet, M; Müller, S; Pot, C; Mathias, A; Du Pasquier, R; Hoepner, R; Chan, A; Disanto, G; Zecca, C; Conen, D; Buser, A; DSouza, M; Yaldizli, Ö; Derfuss, T; Gobbi, C; Khalil, M; Brassat, D; Janiaud, PMC; Hemkens, L; Oksenberg, JR; Wiendl, H; Berger, K; Hermesdorf, M; Piehl, F; Kappos, L; Abdelhak, A; Granziera, C; Willemse, E; Leppert, D; Kuhle, J Serum glial fibrillary acidic protein (sGFAP) levels are reduced by fingolimod treatment and prognosticate disease progression independent of relapse activity in multiple sclerosis
MULT SCLER J. 2024; 30(3):56-58.-40th ECTRIMS Congress; SEP 18-20, 2024; Copenhagen, DENMARK. [Oral Communication]
Web of Science

 

MONEDEIRO, F; ZÜGNER, E;, PRIETL, B; OBERHUBER, M; STRADNER, M; KHALIL, M; MAGNES, C; PIEBER, TR Immunometabolomics Reveals Little Autoimmunity in Type 1 Diabetes (T1D)—Cross-Sectional Pathway Analysis across Multiple Autoimmune Diseases
Diabetes 14 June 2024; 73 (Supplement_1): 2020–LB. 2024; -84th scientific session; ADA,; JUN 21-24,2024; Orlando, USA. [Poster]
FullText

 

Pinter, D; Helmlinger, B; Hechenberger, S; Leitner, M; Wurth, S; Damulina, A; Demjaha, R; Khalil, M; Enzinger, C Predictive value and changes of psychological resilience in people with multiple sclerosis: a longitudinal cohort study
MULT SCLER J. 2024; 30(3): 432-433. [Poster]
Web of Science

 

Schnabl, A; Ellmeier, E; Stracke, A; Seifried, K; Tafrali, C; Demjaha, R; Wurth, S; Khalil, M; Angiari, S Targeting pyruvate kinase M2 to limit T cell pathogenicity in multiple sclerosis
EUR J IMMUNOL. 2024; 54: 74-74.-7th European Conference of Immunology; SEP 01-04, 2024; Dublin, IRELAND. [Oral Communication]
Web of Science

 

Schnabl, A; Ellmeier, E; Stracke, A; Seifried, K; Tafrali, C; Demjaha, R; Wurth, S; Khalil, M; Angiari, S Targeting pyruvate kinase M2 to limit T cell pathogenicity in multiple sclerosis.
Österreichische Gesellschaft für Neurologie (ÖGN) annual meeting 2024; March 13-15, 2024; Vienna, Austria. 2024. [Poster]

 

Tafrali, C; Martinez-Serrat, M; Demjaha, R.; Hechenberger, S; Helmlinger, B; Opriessnig, P; Pinter, D; Damulina, A; Wurth, S; Heschl, B; Leppert, D; Benkert, P; Kuhle, J; Ropele, S; Enzinger, C; Khalil, M Choroid plexus volume and serum neurofilament light levels in relation to brain atrophy and lesion load in multiple sclerosis.
CSF Society ; Jun 27-28, 2024; Barcelona, SPAIN. 2024. [Oral Communication]
FullText

 

Benkert, P; Maceski, AM; Schädelin, S; Willemse, E; Meier, S; Melie-Garcia, L; Cagol, A; Galbusera, R; Subramaniam, S; Lorscheider, J; Fischer-Barnicol, B; Achtnichts, L; Findling, O; Lalive, P; Bridel, C; Müller, S; Pot, C; Mathias, A; Du Pasquier, R; Salmen, A; Hoepner, R; Chan, A; Disanto, G; Zecca, C; Orleth, A; DSouza, M; Yaldizli, Ö; Derfuss, T; Oechtering, J; Gobbi, C; Khalil, M; Abdelhak, A; Oksenberg, JR; Hermesdorf, M; Berger, K; Wiendl, H; Piehl, F; Conen, D; Buser, A; Kappos, L; Granziera, C; Leppert, D; Kuhle, J Serum glial fibrillary acidic protein (GFAP) is a longitudinal indicator of disease progression in MS while neurofilament light chain (NfL) associates with therapy response in patients under B-cell depleting therapy
MULT SCLER J. 2023; 29: 58-60.-9th Joint ECTRIMS-ACTRIMS meeting; OCT 11-13, 2023; Milan, ITALY. [Poster]
Web of Science

 

Damulina, A; Pirpamer, L; Demjaha, R; Tafrali, C; Wurth, S; Heschl, B; Hochmeister, S; Garcia, JJA; Opriessnig, P; Ropele, S; Enzinger, C; Khalil, M Intrathecal kappa free light chains indicate higher MRI lesion burden in patients with multiple sclerosis
MULT SCLER J. 2023; 29: 565-565. [Poster]
Web of Science FullText

 

Demjaha, R; Hechenberger, S; Buchmann, A; Helmlinger, B; Heschl, B; Wurth, S; Opriessnig, P; Ropele, S; Leppert, D; Benkert, P; Kuhle, J; Enzinger, C; Pinter, D; Khalil, M Serum NfL levels and cognitive performance in persons with multiple sclerosis
EUR J NEUROL. Abstracts. 2023; 30(S1):226-226.-9th Congress of the European Academy of Neurology; JUL 1-4, 2023; Budapest, HUNGARY. [Poster]
Web of Science

 

Demjaha, R; Hechenberger, S; Buchmann, A; Helmlinger, B; Heschl, B; Wurth, S; Opriessnig, P; Ropele, S; Leppert, D; Benkert, P; Kuhle, J; Enzinger, C; Pinter, D; Khalil, M Serum NfL levels and cognitive performance in persons with multiple sclerosis
MULT SCLER J. 2023; 29: 297-298.-9th Joint ECTRIMS-ACTRIMS meeting; OCT 11-13, 2023; Milan, ITALY. [Poster]
Web of Science

 

Demjaha, R; Hechenberger, S; Buchmann, A; Helmlinger, B; Heschl, B; Wurth, S; Opriessnig, P; Ropele, S; Leppert, D; Kuhle, J; Enzinger, C; Pinter, D; Khalil, M Serum NfL levels and cognitive performance in persons with multiple sclerosis.
Proceedings of DGLN 2023. 2023; -Jahrestagung DGLN 2023; MAY 5-6, 2023; Dresden, GERMANY. [Poster]

 

Demjaha, R; Hechenberger, S; Buchmann, A; Helmlinger, B; Heschl, B; Wurth, S; Opriessnig, P; Ropele, S; Leppert, D; Kuhle, J; Enzinger, C; Pinter, D; Khalil, M Serum NfL levels and cognitive performance in persons with multiple sclerosis.
BraYn Conference 2023 - 6th Research Assembly. 2023; -BraYn Conference 2023; SEP 27-29, 2023; Naples, ITALY. [Poster]

 

Demjaha, R; Hofer, E; Buchmann, A; Pirpamer, L; Pinter, D; Leppert, D; Benkert, P; Kuhle, J; Ropele, S; Schmidt, R; Cole, JH; Enzinger, C; Khalil, M Serum neurofilament light levels in relation to the Brain Age Paradigm in normal ageing.
Med Uni Graz - Doctoral Day; FEB 9, 2023; Graz, AUSTRIA. 2023. [Poster]

 

Ellmeier, E; Schnabl, A; Seifried, K; Stracke, A; Tafrali, C; Demjaha, R; Khalil, M; Angiari, S Targeting pyruvate kinase M2 to limit T cell pathogenicity in multiple sclerosis
ÖGAI Annual Meeting; September 14-16, 2023; Linz, AUSTRIA. 2023. [Oral Communication]

 

Ellmeier, E; Stracke, A; Seifried, K; Tafrali, C; Khalil, M; Angiari, S Targeting pyruvate kinase M2 to limit T cell pathogenicity in multiple sclerosis
6th BraYn Conference; September 27-29, 2023; Naples, ITALY. 2023. [Oral Communication]

 

Hechenberger, S; Helmlinger, B; Fruhwirth, V; Ropele, S; Wurth, S; Damulina, A; Eppinger, S; Demjaha, R; Khalil, M; Enzinger, C; Pinter, D Evaluierung eines selbst-administrierten-IPad-basierten Tests zur Messung der Verarbeitungsgeschwindigkeit bei Personen mit Multipler Sklerose
Neurologisch Kongressband 2023. 2023; -20. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 22-24, 2023; Bregenz, AUSTRIA. [Poster]

 

Hechenberger, S; Helmlinger, B; Tinauer, C; Fruhwirth, VM; Ropele, S; Wurth, S; Damulina, A; Eppinger, S; Demjaha, R; Khalil, M; Enzinger, C; Pinter, D Evaluation of a Self-Administered iPad-Based Test to Measure Processing Speed in People with Multiple Sclerosis
MULT SCLER J. 2023; 29: 190-190.-9th Joint ECTRIMS-ACTRIMS meeting; OCT 11-13, 2023; Milan, ITALY. [Poster]
Web of Science FullText

 

Hechenberger, S; Pirpamer, L; Helmlinger, B; Fruhwirth, V; Wurth, S; Damulina, A; Eppinger, S; Demjaha, R; Khalil, M; Enzinger, C; Penner, IK; Pinter, D Factors Influencing Fatigue in Persons with Multiple Sclerosis: Contribution of Psychological and Magnetic Resonance Imaging Assessment
INGE ST - Tag 2023; JUN 19; Graz, AUSTRIA. 2023. [Poster]

 

Helmlinger, B; Hechenberger, S; Fruhwirth, V; Wurth, S; Damulina, A; Eppinger, S; Demjaha, R; Khalil, M; Enzinger, C; Pinter, D Der Einfluss von Selbstwirksamkeit auf Depressivität und Ängstlichkeit bei Personen mit Multipler Sklerose
Neurologisch Kongressband. 2023; -20. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 22-24, 2023; Bregenz, AUSTRIA. [Poster]

 

Helmlinger, B; Seebacher, B; Ropele, S; Hechenberger, S; Opriessnig, P; Reishofer, G; Valsasina, P; Rocca, MA; Filippi, M; Heschl, B; Ehling, R; Reindl, M; Khalil, M; Enzinger, C; Deisenhammer, F; Brenneis, C; Pinter, D Effects of Actual and Imagined Music-Cued Gait Training on Motor Functioning and Brain Activation In People with Multiple Sclerosis: A Randomised Multicentre Study - Part 2: Outcomes from task-fMRI
MULT SCLER J. 2023; 29: 515-516.-9th Joint ECTRIMS-ACTRIMS meeting; OCT 11-13, 2023; Milan, ITALY. [Poster]
Web of Science

 

Helmlinger, B; Seebacher, B; Ropele, S; Hechenberger, S; Reishofer, G; Heschl, B; Ehling, R; Reindl, M; Khalil, M; Enzinger, C; Deisenhammer, F; Brenneis, C; Pinter, D Effects of Music-Cued Gait Training on Neuronal Reorganization in People with Multiple Sclerosis
INGE-St Research Day; JUNE 19, 2023; Graz. 2023. [Poster]

 

Janiaud, P; Benkert, P; Achtnichts, L; Bar-Or, A; Lang, VB; Bridel, C; Comabella, M; Disanto, G; Findling, O; Gobbi, C; Granziera, C; Herwerth, M; Hoepner, R; Horakova, D; Kamber, N; Khalil, M; Kunz, P; Lalive, P; Linker, R; Lorscheider, J; Müller, S; Oechtering, J; Pettypool, V; Piehl, F; Pot, C; Roth, P; Théaudin, M; Tintoré, M; Tur, C; Uffer, D; Vehoff, J; Wiendl, H; Ziemssen, T; Zecca, C; Salmen, A; Leppert, D; Derfuss, T; Kappos, L; Kuhle, J; Hemkens, L; Yaldizli, Ö Personalized treatment decision algorithms for the clinical implementation of serum neurofilament light chain in multiple sclerosis: a modified Delphi study
MULT SCLER J. 2023; 29: 961-963. [Poster]
Web of Science

 

Khalil, M Body fluid biomarkers - which biomarker and when?
MULT SCLER J. 2023; 29: 10-10. [Poster]
Web of Science

 

Khalil, M Biomarker Highlights
MS Summit 2023 - Pushing the boundaries; 7.12.2023; Linz, AUSTRIA. 2023. [Oral Communication]

 

Khalil, M Biomarker bei Multipler Sklerose
51. Steirische Herbstfortbildung; 6.10.2023; Graz, AUSTRIA. 2023. [Oral Communication]

 

Khalil, M Präzisionsmedizin in der Multiplen Sklerose (MS): Personalisierte Diagnostik, Zielgerichtete Therapie und die Zukünftige Rolle von AI in der MS
Biogen Science Forum ; 23.11.2023; Vienna, AUSTRIA. 2023. [Oral Communication]

 

Khalil, M Neurologische Komplikationen von Immuncheckpoint-Inhibitoren und CAR T-Zell Therapien
Klinikfortbildung ; 2.11.2023; Graz, AUSTRIA. 2023. [Oral Communication]

 

Khalil, M Neurologische Nebenwirkungen onkologischer Immuntherapien
Neurologie Update Refresher Wien - Forum Medizin Fortbildung ; 28.11.2023; Vienna, AUSTRIA. 2023. [Oral Communication]

 

Khalil, M Saures Gliafaserprotein (GFAP) als Marker der Krankheitsprogression bei entzündlich demyelinisierenden Erkrankungen des ZNS
20. Jahrestagung der Österreichischen Gesellschaft für Neurologie; März 22-24, 2023; Bregenz. 2023. [Oral Communication]

 

Khalil, M Genetik der MS
MS Insights; MAT 3-4,2023; Vienna, AUSTRIA. 2023. [Oral Communication]

 

Khalil, M Biomarker: Ihre Schwächen und Stärken
20. Jahrestagung der Österreichischen Gesellschaft für Neurologie; März, 22-24; Bregenz, Austria. 2023. [Oral Communication]

 

Meier, S; Benkert, P; Maceski, AM; Schaedelin, S; Oechtering, J; Melie-Garcia, L; Cagol, A; Barakovic, M; Galbusera, R; Achtnichts, L; Lalive, PH; Bridel, C; Müller, S; Pot, C; Salmen, A; Disanto, G; Zecca, C; Abdelhak, A; Barro, C; Thebault, S; D'Souza, M; Derfuss, T; Orleth, A; Khalil, M; Yaldizli, Ö; Hermesdorf, M; Wiendl, H; Piehl, F; Fischer, U; Kappos, L; Gobbi, C; Granziera, C; Leppert, D; Willemse, EAJ; Kuhle, J Serum Glial Fibrillary Acidic Protein compared with Neurofilament Light Chain as Biomarker for Multiple Sclerosis Disease Progression
NEUROLOGY. 2023; 100(17): 3113 Doi: 10.1212/WNL.0000000000203030 [Poster]
Web of Science FullText FullText_MUG

 

Pichler, A; Eichlseder, M; Khalil, M; Fandler-Hoefler, S; Meinitzer, A; Essber, H; Reiterer, C; Kurz, A Association of Perioperative Serum Neurofilament Light Chain Levels with Inflammation Induced Alterations of the Kynurenine Pathway: A Study Protocol for a Prospective, Multicenter, Observational Study
Session PP18 - Perioperative Medicine. 2023; -Anesthesiology annual meeting 2023; OCT 13-17, 2023; San Francisco, CA, USA;. [Poster]
FullText

 

Prietl, B; Herbsthofer, L; Vera-Ramos, J; Pfeifer, V; Khalil, M; Stradner, MH; Sourij, H; Pieber, TR Identification of important shared and diverse immunephenotypes in type 1 diabetes, multiple sclerosis and systemic lupus erythematosus using automated cluster analysis by machine learning
DIABETOLOGIA. 2023; 66(SUPPL 1):S226-S226.-59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 02-06, 2023; Hamburg, GERMANY. [Poster]
Web of Science

 

Prietl, B; Vera-Ramos, J; Herbsthofer, L; Pfeifer, V; Khalil, M; Stradner, M; Sourij, H; Pieber, T Automated cluster analysis by machine learning helps to identify shared and diverse immune phenotypes of T1D, MS and SLE
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(Suppl7):S775-S775.-51. Jahrestagung der ÖDG; NOV 16-18, 2023; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

 

Prietl, B; Vera-Ramos, JA; Pfeifer, V; Khalil, M; Herbsthofer, L; Sorij, H; Pieber, TR Automated cluster analysis by machine learning reveals important dissimilarities in the immune phenotype of T1D, MS and SLE
Proceedings of the 83rd ADA. 2023; -83rd scientific session of the American Diabetes Association (ADA); June 23-26, 2023; San Diego, CA, USA. [Oral Communication]

 

Queissner, R; Khalil, M; Fellendorf, F; Birner, A; Dalkner, N; Platzer, M; Maget ,A; Tmava, A; Häussl, A; Reininghaus, E; Neuro-axonal Biomarkers and manic episodes in Bipolar disorder
Proceedings CINP World Congress. 2023; -CINP- World Congress; MAY 7-10, 2023; Montreal, CANADA. [Poster]

 

Seebacher, B; Helmlinger, B; Ehling, R; Heschl, B; Hechenberger, S; Reindl, M; Khalil, M; Enzinger, C; Deisenhammer, F; Brenneis, C; Pinter, D Effects of actual and imagined music-cued gait training on motor functioning and brain activity in people with multiple sclerosis: a randomised multicentre study - Part 1: behavioural outcomes
MULT SCLER J. 2023; 29: 88-89.-9th Joint ECTRIMS-ACTRIMS meeting; OCT 11-13, 2023; Milan, ITALY. [Oral Communication]
Web of Science

 

Seifried, K; Paar, M; Cvirn, G; Buchmann, A; Khalil, M; Oettl, K Redox state of human serum albumin in serum and cerebrospinal fluid of multiple sclerosis patients
Doctoral Day 2023; FEB 9, 2023; Graz. 2023. [Poster]

 

Buchmann, A; Pirpamer, L; Pinter, D; Voortman, M; Helmlinger, B; Pichler, A; Bachmaier, G; Reindl, M; Ropele, S; Enzinger, C; Khalil, M. High serum neurofilament light levels correlate with physical disability and brain atrophy in multiple sclerosis.
DocDay2022; FEB 10, 2022; Graz, AUSTRIA. 2022. [Onlinepräsentation]

 

Callegari, I; Oechtering, J; Kim, HI; Schneider, M; Holdermann, S; Kuhle, J; Khalil, M; Kapfhammer, J; Kappos, L; Junker, A; Sanderson, N; Derfuss, T Intrathecal IgM response in MS contains brain reactive antibodies
MULT SCLER J. 2022; 28(3_SUPPL):36-36.-38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis; OCT 26-28, 2022; Amsterdam, NETHERLANDS. [Oral Communication]
Web of Science

 

Demjaha, R; Hofer, E; Pirpamer, L; Buchmann, A; Pinter, D; Leppert, D; Benkert, P; Kuhle, J; Ropele, S; Schmidt, R; Cole, J; Enzinger, C; Khalil, M Serum neurofilament light levels in relation to the Brain-Age Paradigm in normal ageing
EUR J NEUROL. 2022; 29: 503-503. [Oral Communication]
Web of Science

 

Demjaha, R; Hofer, E; Pirpamer, L; Buchmann, A; Pinter, D; Leppert, D; Benkert, P; Kuhle, J; Ropele, S; Schmidt, R; Cole, JH; Enzinger, C; Khalil, M Serum neurofilament light levels in relation to the Brain-Age Paradigm in normal ageing
MULT SCLER J. 2022; 28(3_SUPPL):588-589.-38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis; OCT 26-28, 2022; Amsterdam, NETHERLANDS. [Oral Communication]
Web of Science

 

Demjaha, R; Hofer, E; Pirpamer, L; Buchmann, A; Pinter, D; Leppert, D; Benkert, P; Kuhle, J; Ropele, S; Schmidt, R; Cole, JH; Enzinger, C; Khalil, M Serum neurofilament light levels in relation to the Brain-Age Paradigm in normal ageing.
19. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAY 18-20; Graz. 2022. [Poster]

 

Demjaha, R; Hofer, E; Pirpamer, L; Buchmann, A; Pinter, D; Leppert, D; Benkert, P; Kuhle, J; Ropele, S; Schmidt, R; Cole, JH; Enzinger, C; Khalil, M Serum neurofilament light levels in relation to the Brain-Age Paradigm in normal ageing.
University of Business and Technology (UBT) - Global UBT Fest; JUL 12-14, 2022; Prishtine. 2022. [Oral Communication]

 

Dreo, B; Muralikrishnan, A; Husic1, R;Fessler, J; Lackner, A; Bosch, P; Rupp, J; Buchmann, A; Khalil, M; Thiel, J; Stradner, M Differential STAT activation in patients with active rheumatoid arthritis
Abstract Book of the European Workshop for Rheumatology Research (EWRR) 2022. 2022; -European Workshop for Rheumatology Research (EWRR); MAY 5-8, 2022; Vienna, Austria. [Poster]

 

Franthal, S; Khalil, M; Buchmann, A; Pirpamer, L; Katschnig-Winter, P; Kögl-Hammer, M; Homayoon, N; Wenzel, K; Schmidt, R; Schwingenschuh, P Neurofilament light chain protein (NfL) is elevated in Essential Tremor
Neurologisch Sonderheft ÖGN Abstract 2022. 2022; -19. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR 18-20, 2022; Graz. [Oral Communication]
FullText

 

Franthal, S; Khalil, M; Pirpamer, L; Buchmann, A; Katschnig-Winter, P; Kögl-Hammer, M; Homayoon, N; Wenzel, K; Schmidt, R; Schwingenschuh, P Neurofilament light chain protein (NfL) is elevated in Essential Tremor
Mov Disord. 2022. 2022; 37 (suppl 1): -International Congress of Parkinson’s Disease and Movement Disorders ; SEP 15-18, 2022; Madrid, Spain. [Onlinepräsentation]
FullText

 

Haindl, MT; Üçal, M; Nowakowska, M; Jerkovic, A; Khalil, M; Enzinger, C; Hochmeister, S Die leichte Proteinkette des Neurofilaments als potentieller Biomarker der Krankheitsprogression in einem neuen Tiermodell der Multiplen Sklerose
https://az659834.vo.msecnd.net/eventsairwesteuprod/production-cmi-public/7bd333cd5c824b0d8e1294e52d4a4988. 2022; 1/22: 58-59.-19. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAI 18-20, 2022; Graz, AUSTRIA. [Poster]
FullText

 

Hanemann, CO; Abdelrahman, A; Adams, C; Sahm, F; Urbanic-Purkart, T; Khalil, M; Vergura, R; Morelli, C MIR-497 AND 219 IN BLOOD AID MENINGIOMA CLASSIFICATION MIR-497 AND 219 IN BLOOD AID MENINGIOMA CLASSIFICATION
NEURO-ONCOLOGY. 2022; 24: 17-17.-27th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO); NOV 16-20, 2022; Tampa, FL. [Oral Communication]
Web of Science

 

Hechenberger, S; Helmlinger, B; Fruhwirth, V; Wurth, S; Damulina, A; Eppinger, S; Demjaha, R; Khalil, M; Enzinger, C; Pinter, D Evaluation of a Self-administered, IPad-based Processing Speed Test for People with Multiple Sclerosis
MULT SCLER J. 2022; 28(2_SUPPL): 12-13. [Poster]
Web of Science

 

Hechenberger, S; Pinter, D; Khalil, M; Pirpamer, L; Damulina, A; Pichler, A; Fruhwirth, V; Ropele, S; Schmidt, R; Fuchs, S; Enzinger, C Long-term Course and Morphological MRI Correlates of Cognitive Function in Multiple Sclerosis
Annual Meeting of the International Multiple Sclerosis Cognition Society (IMSCOGS); MAI 18-19, 2022; Bordeaux, FRANCE. 2022. [Oral Communication]

 

Hechenberger, S; Pirpamer, L; Fruhwirth, V; Berger, L; Helmliger, B; Wurth, S; Damulina, A; Eppinger, S; Khalil, M; Enzinger, C; Penner, IK; Pinter, D Veränderungen der Gehirnstruktur bei Personen mit Multipler Sklerose und Fatigue
19. Jahrestagung der österreichischen Gesellschaft für Neurologie; MAI 18-22, 2022; Graz. 2022. [Oral Communication]

 

Hechenberger, S; Pirpamer, L; Fruhwirth, V; Berger, L; Helmlinger, B; Wurth, S; Damulina, A; Eppinger, S; Khalil, M; Enzinger, C; Penner, I; Pinter, D Structural Brain Changes Associated with Fatigue in People with Multiple Sclerosis
EUR J NEUROL. Proceedings of the 8th Congress of the EAN. 2022; 29: 222-222.-8th Congress of the European-Academy-of-Neurology (EAN); JUN 25-28, 2022; Vienna, AUSTRIA. [Poster]
Web of Science

 

Hechenberger, S; Pirpamer, L; Fruhwirth, V; Berger, L; Helmlinger, B; Wurth, S; Damulina, A; Eppinger, S; Khalil, M; Enzinger, C; Penner, IK; Pinter, D Structural Brain Changes Associated with Fatigue in People with Multiple Sclerosis
8th Congress of the European Academy of Neurology - Europe 2022; JUN 25-28, 2022; Vienna, AUSTRIA. 2022. [Onlinepräsentation]

 

Hechenberger, S; Pirpamer, L; Helmlinger, B; Fruhwirth, V; Wurth, S; Damulina, A; Eppinger, S; Demjaha, R; Khalil, M; Enzinger, C; Penner, IK; Pinter, D Factors influencing fatigue in persons with multiple sclerosis: contribution of psychological and magnetic resonance imaging assessment
MULT SCLER J. 2022; 28(3_SUPPL): 436-437. [Poster]
Web of Science FullText

 

Hegen, H; Arrambide, G; Berek, K; Gnanapavan, S; Kaplan, B; Khalil, M; Saadeh, R; Teunissen, C; Tumani, H; Villar, LM; Walde, J; Willrich, MAV; Zetterberg, H; Deisenhammer, F Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: a systematic review, meta-analysis and consensus statement
MULT SCLER J. 2022; 28(3_SUPPL):44-46.-38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis; OCT 26-28, 2022; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Helmlinger, B; Hechenberger, S; Fruhwirth, V; Wurth, S; Damulina, A; Eppinger, S; Demjaha, R; Khalil, M; Enzinger, C; Pinter, D Self-efficacy influences depression and anxiety in a cross-sectional cohort of people with multiple sclerosis
MULT SCLER J. 2022; 28(3_SUPPL):907-907.-38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis; OCT 26-28, 2022; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Helmlinger, B; Seebacher, B; Reishofer, G; Hechenberger, S; Ropele, S; Khalil, M; Enzinger, C; Pinter, D Brain Activation Patterns During Actual and Imagined Movement to Rhythmic Auditory Stimulation.
EUR J NEUROL. 2022; 29: -8th Congress of the EAN; JUNE 25-28, 2022; Vienna, AUSTRIA. [Poster]

 

Helmlinger, B; Seebacher, B; Reishofer, G; Hechenberger, S; Ropele, S; Khalil, M; Enzinger, C; Pinter D Gehirnaktivierungen bei Bewegung und Bewegungsvorstellung mit Auditorischen Hinweisreizen.
19. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAY 18-20, 2022; Graz, AUSTRIA. 2022. [Poster]

 

Hodl, I; Sallegger, C; Forstner, P; Sareban, N; Moritz, M; Dreo, B; Schulz, E; Lackner, A; Kleinhappl, B; Hatzl, S; Moazedi-Fürst, F; Seifert-Held, T; Heschl, B; Khalil, M; Enzinger, C; Greinix, H; Stradner, MH; Steinmetz, I; Schlenke, P; Fessler, J Altered cellular immune response to vaccination against SARS-CoV-2 in patients suffering from autoimmunity with B-cell depleting therapy.
ÖGR Jahrestagung 2022; NOV 3-5, 2022; Vienna, AUSTRIA. 2022. [Poster]

 

Khalil, M NfL bei Schlaganfall und Hirnblutungen.
39. Jahrestagung der DGNI und DSG Arbeitstagung NeuroIntensivMedizin ANIM 2022; JAN 20,2022; Ludwigsburg, GERMANY. 2022. [Oral Communication]

 

Khalil, M Blood based biomarkers: when to implement? NfL use in clinical practice: normal reference values
MULT SCLER SUPPL. 2022; -ECTRIMS ; OCT 26-28, 2022; Amsterdam, The Netherlands. [Oral Communication]
FullText

 

Khalil, M Fortbildungsakademie 16 – Liquordiagnostik Liquor-Spezial-Programm zum Erregernachweis
ÖGN Jahrestagung; MAY 18-20, 2022; Graz, AUSTRIA. 2022. [Oral Communication]

 

Khalil, M Diagnostische und prognostische Bedeutung von Degenerationsmarkern
ÖGN Jahrestagung, AG für Neuroimmunologie, Neuro-Labordiagnostik, NMO, Neuroonkologie und Autoimmunencephalitis; MAY 17, 2022; Graz, Austria. 2022. [Oral Communication]

 

Khalil, M Neurofilamente - bereit für den Einsatz in der Praxis?
ÖGN Jahrestagung ; MAY 18-20, 2022; Graz, AUSTRIA. 2022. [Oral Communication]

 

Khalil, M Fluid Biomarkers
Other biomarkers: GFAP, CXCL-13...and others
CEMCAT - Educational program in MS: focus on patient monitoring and fluid biomarkers; SEP 20, 2022; Barcelona, SPAIN. 2022. [Oral Communication]

 

Khalil, M Etablierte und zukünftige Biomarker - wo stehen wir in Bezug auf Praxiseinsatz?
MS Akademie ; SEP 30-OCT 1, 2022; Mondsee, AUSTRIA. 2022. [Oral Communication]

 

Khalil, M NEBENWIRKUNGSMANAGEMENT BEI IMMUNTHERAPIEN AUF DAS NEUROLOGISCHE SYSTEM
FRÜHJAHRSTAGUNG 2022 OeGHO; APR 09-10, 2022; Graz, AUSTRIA. 2022. [Oral Communication]

 

Khalil, M MS Zentrumstreffen - Update Safety DMT
MS Zentrumstreffen ; OCT 1, 2022; Mondsee, AUSTRIA. 2022. [Oral Communication]

 

Khalil, M NfL as prognostic tool and important confounders in its interpretation
CMSC Annual Meeting June 1 – 4 | Gaylord National Resort & Convention Center | National Harbor, Maryland; JUN 1-4, 2022; National Harbor, Maryland, USA. 2022. [Oral Communication]
FullText

 

Khalil, M NfL use in clinical practice: normal reference values
MULT SCLER J. 2022; 28(3_SUPPL):121-122.-38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis; OCT 26-28, 2022; Amsterdam, NETHERLANDS. [Oral Communication]
Web of Science

 

Khalil, M Update on body fluid biomarkers in Multiple Sclerosis
AKADEMIJA OB PRIDOBITVI NAZIVA KLINIKA IN 50-LETNICI ODDELKA ZA NEVROLOGIJO; SEP 23, 2022; Maribor, SLOVENIA. 2022. [Oral Communication]

 

Khalil, M; Enzinger, C Sind Guidelines zum Einsatz der MRT bei MS wertvoll? Eine Standortbestimmung anhand von Fallbeispielen
MS Akademie ; SEP 30-OCT 1, 2022; Mondsee, Austria. 2022. [Oral Communication]

 

Meier, S; Benkert, P; Maceski, A; Schaedelin, S; Garcia, LM; Cagol, A; Barakovic, M; Galbusera, R; Subramaniam, S; Achtnichts, L; Lalive, PH; Bridel, C; Muller, S; Pot, C; Salmen, A; Disanto, G; Zecca, C; Orleth, A; Khalil, M; Yaldizli, O; Oechtering, J; Battaglini, M; Kappos, L; Derfuss, T; Leppert, D; Gobbi, C; Granziera, C; Willemse, EAJ; Kuhle, J Serum glial fibrillary acidic protein compared with neurofilament light chain as biomarker for multiple sclerosis disease progression
MULT SCLER J. 2022; 28(3_SUPPL):122-123.-38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis; OCT 26-28, 2022; Amsterdam, NETHERLANDS. [Oral Communication]
Web of Science

 

Queissner, R; Khalil, M; Lenger, M; Birner, A.; Fellendorf, F; Platzer, M; Maget, A; Tmava-Berisha, A; Häussl, A; Reininghaus, E; Neurofilament und Krankheitsdauer bei bipolarer affektiver Störung
Kongressprogramm des DGPPN-Kongress 2022. 2022; -DGPPN-KOngress; NOV 23-26, 2022; Berlin. [Poster]

 

Ruggieri, S; Prosperini, L; Al-Araji, S; Annovazzi, P; Bisecco, A; Ciccarelli, O; De Stefano, N; Filippi, M; Fleischer, V; Evangelou, N; Enzinger, C; Gallo, A; Garjani, A; Groppa, S; Haggiag, S; Khalil, M; Lucchini, M; Mirabella, M; Montalban, X; Pozzilli, C; Preziosa, P; Rio, J; Rocca, MA; Rovira, A; Stromillo, ML; Zaffaroni, M; Tortorella, C; Gasperini, C Assessing treatment response to oral drugs for multiple sclerosis in real world setting: a MAGNIMS study
MULT SCLER J. 2022; 28(3_SUPPL):657-659.-38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis; OCT 26-28, 2022; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Weiss, B; Pichler, A; Damulina, A; Seifert-Held, T; Enzinger, C; Archelos-Garcia, J; Khalil, M Cerebrospinal fluid kappa free light chains in patients with an isolated band in isoelectric focusing
EUR J NEUROL. 2022; 29: 301-301. [Poster]
Web of Science

 

Woltsche, N; Valentin, K; Höfechner, L; Guttmann, A; Riedl, R; Buchmann, A; Lindner, M; Schmetterer, L; Khalil, M; Lindner, E Neuroflament Leichtketten – neuer Marker für neuronale Degeneration im Kammerwasser von Glaukom-Patient*innen
Br J Ophthalmol. 2022; -DOG - Kongress 2022; SEP 29 - OKT 2; Berlin, GERMANY. [Oral Communication]
FullText

 

Woltsche, N; Valentin, K; Höflechner, L; Guttmann, A; Horwath-Winter, J; Schneider, MR; Ivastinovic, D; Lindner, M; Schmetterer, L; Singh, N; Riedl, R; Buchmann, A; Khalil, M; Lindner, E Neurofilament light chain - a new marker for neuronal decay in the aqueous humor of glaucoma patients
Br J Ophthalmol. 2022; -European Glaucoma Society; JUN 4-8, 2022; Athen, GREECE. [Poster]
FullText

 

Woltsche, N; Valentin, K; Höflechner, L; Guttmann, A; Riedl, R; Khalil, M; Lindner, E Neurofilament Leichtketten – ein neuer Biomarker für neuronale Degeneration im Kammerwasser von Glaukom-Patient*innen
Spektrum der Augenheilkunde. 2022; -62. Jahrestagung der Österreichischen Ophthalmologischen Gesellschaft; MAY 26-28, 2022; Villach, AUSTRIA. [Poster]

 

Buchmann, A; Pirpamer, L; Pinter, D; Voortman, M; Helmlinger, B; Pichler, A; Bachmaier, G; Ropele, S; Enzinger, C; Khalil, M Serum Neurofilament Light Levels Correlate with Reduced Gray Matter Volume in Advanced Multiple Sclerosis
NEUROLOGY. 2021; 96(15): [Poster]
Web of Science FullText

 

Filippi, M; Preziosa, P; Meani, A; Rovira, A; Mesaros, S; Ciccarelli, O; Battisti, JLF; Enzinger, C; Barkhof, F; Gasperini, C; Fainardi, E; Brownlee, W; Drulovic, J; Montalban, X; Cramer, SP; Khalil, M; Hagens, M; Ruggieri, S; Dalla Costa, G; Martinelli, V; Miszkiel, K; Tintore, M; Comi, G; Dekker, I; Uitdehaag, B; Ivanovic, J; Amato, MP; Rocca, MA Comparison of the 2017 and 2010 Revisions of the McDonald Criteria in Patients with CIS Suggestive of MS: A Multicentre MAGNIMS Study
NEUROLOGY. Supplement. 2021; 96(15): [Poster]
Web of Science

 

Filippi, M; Preziosa, P; Meani, A; Rovira, A; Mesaros, S; Ciccarelli, O; Frederiksen, J; Enzinger, C; Barkhof, F; Gasperini, C; Fainardi, E; Brownlee, W; Drulovic, J; Montalban, X; Khalil, M; Hagens, M; Ruggieri, S; Dalla Costa, G; Tintore, M; Comi, G; Dekker, I; Uitdehaag, B; Ivanovic, J; Amato, M; Rocca, M Comparison of the 2017 and 2010 revisions of the McDonald criteria CIS patients: a multicentre MAGNIMS study
EUR J NEUROL. 2021; 28: 203-203.-EAN Virtual 2021; [Oral Communication]
Web of Science

 

Franthal, S; Khalil, M; Pirpamer, L; Kögl-Hammer, M; Katschnig-Winter,P; Homayoon,N; Wenzel,K; Schmidt,R; Schwingenschuh, P Neurofilament light chain protein (NfL) is elevated in Essential Tremor
Jahrestagung der österreichischen Parkinsongesellschaft; Okt 20-22; 2021; Graz, AUSTRIA. 2021. [Oral Communication]

 

Hechenberger, S; Pinter, D; Helmlinger, B; Ropele, S; Pichler, A; Khalil, M; Enzinger, C Impaired processing speed increases risk for disability progression in patients with MS
ÖGN 2021. 18. Jahrestagung der Österreichischen Gesellschaft für Neurologie; APR 9-10, 2021; Tulln, AUSTRIA. 2021. [Poster]

 

Hechenberger, S; Pinter, D; Helmlinger, B; Ropele, S; Pichler, A; Khalil, M; Enzinger, C Beeinträchtigung in der Verarbeitungsgeschwindigkeit steigert das Risiko einer Krankheitsprogression bei Patient*innen mit Multipler Sklerose (MS)
Journal of Neuropsychology. 2021; -Jahrestagung der Österreichischen Gesellschaft für Neuropsychologie (GNPÖ); OKT 8-9, 2021; Vienna, AUSTRIA. [Oral Communication]

 

Hechenberger, S; Pirpamer, L; Fruhwirth, V; Berger, L; Helmlinger, B; Wurth, S; Damulina, A; Khalil, M; Enzinger, C; Penner, IK; Pinter, D Morphological correlates of fatigue in patients with multiple sclerosis
MULT SCLER J. 2021; 27(2_SUPPL): 257-258. [Poster]
Web of Science

 

Helmlinger, B; Pinter, D; Gassner, B; Khalil, M; Heschl, B; Damulina, A; Pichler, A; Enzinger, C The timed 25-foot walk usefully complements the EDSS score in multiple sclerosis
MULT SCLER J. 2021; 27(2_SUPPL):266-266.-37th Congress of ECTRIMS; OCT 13-15; Basel, SWITZERLAND. [Poster]
Web of Science

 

Helmlinger, B; Pinter, D; Gassner, B; Khalil, M; Heschl, B; Damulina, A; Pichler, A; Enzinger, C The Timed 25-Foot Walk usefully complements the EDSS score in Multiple Sclerosis
ÖGN 2021. 18. Jahrestagung der Österreichischen Gesellschaft für Neurologie; APR 9-10, 2021; Tulln, AUSTRIA. 2021. [Poster]

 

Khalil, M UPDATE ZU ETABLIERTEN & ZUKÜNFTIGEN BIOMARKERN, NFL „READY TO GO“ FÜR DIE PRAXIS?
MS Akademie der ÖGN; SEP 24-25, 2021; Vienna (virtuell). 2021. [Oral Communication]

 

Khalil, M Role of CSF Diagnostics in Multiple Sclerosis.
Online PAOKC Neurologie en degeneratieve aandoeningen; NOV 4 2021; Amsterdam, The Netherlands . 2021. [Oral Communication]

 

Khalil, M Immune cells in inflammation and pathophysiology: Neuroinflammation.
FUNDAMENTALS OF IMMUNOLOGY IN HEALTH AND DISEASE (PHD COURSE); NOV 3-5, 2021; Graz, AUSTRIA. 2021. [Oral Communication]

 

Khalil, M Neurofilamente als Biomarker bei neurologischen/neurodegenerativen Erkrankungen
ÖQUASTA Symposium 2021; SEP 30 - OCT 1, 2021; Igls, AUSTRIA. 2021. [Oral Communication]

 

Khalil, M Biomarker in der Liquordiagnostik: Pro und Contra – kappa-Freie Leichtketten
Jahrestagung der DGLN 07. und 08. Mai 2021 (Web-basiert); MAY 7-8, 2021; Erlangen, GERMANY. 2021. [Science to Public]

 

Khalil, M NfL in der klinischen Praxis der MS – Indikator und/oder Prädiktor.
Medical Round Table „Update: NfL in der klinischen Praxis der MS – Indikator und/oder Prädiktor“ ; NOV 9, 2021; Graz, AUSTRIA. 2021. [Oral Communication]

 

Khalil, M Liquor Biomarker für die Diagnose und Prognose neurologischer Erkrankungen.
Neurologie Update Refresher (Forum für medizinische Fortbildung); NOV 30 - DEC 1, 2021; Vienna (virtual), AUSTRIA. 2021. [Oral Communication]

 

Khalil, M BIOMARKER BEI MULTIPLER SKLEROSE - EIN UPDATE.
MS&More; OCT 11, 2021; Leoben, AUSTRIA. 2021. [Oral Communication]

 

Khalil, M Liquor versus blutbasierte Biomarker
ÖGN Programm: Gemeinsame Sitzung der AG Neuroimmunologie/AG Neuro-Labordiagnostik/AG NMO/AG Neuroonkologie/AG Autoimmunencephalitis; OCT 7, 2021; Vienna (virtual), AUSTRIA. 2021. [Oral Communication]

 

Khalil, M Neurofilament und andere Degenerationsmarker
Neurologisches Symposium: Fortschritte in der Neurologie – Rückblick und Perspektiven; SEP 10-11, 2021; Linz. 2021. [Oral Communication]

 

Khalil, M Will Cerebrospinal fluid κ-Free light chains replace Oligoclonal bands? – PRO.
Cerebrospinal Fluid Free Light Chains in Multiple Sclerosis Workshop; OCT 9, 2021; Vienna, AUSTRIA. 2021. [Oral Communication]

 

Khalil, M Differentialdiagnose der MS – Hilfestellungen aus dem Labor: Liquor cerebrospinalis.
20 Jahre Differentialdiagnose der MS: Rückschau, Standortbestimmung, Zukunftsausblick; OCT 9, 2021; Graz, AUSTRIA. 2021. [Oral Communication]

 

Koini, M; Pirpamer, L; Hofer, E; Buchmann, A; Pinter, D; Ropele, S; Enzinger, C; Benkert, P; Leppert, D; Kuhle, J; Schmidt, R; Khalil, M Factors influencing serum neurofilament light chain levels in normal ageing
MULT SCLER J. 2021; 27(2_SUPPL):504-504.-ECTRIMS; OCT 13-15, 2021; virtuell. [Poster]
Web of Science

 

Koini, M; Pirpamer, L; Hofer, E; Buchmann, A; Pinter, D; Ropele, S; Enzinger, C; Benkert, P; Leppert, D; Kuhle, J; Schmidt, R; Khalil, M Factors influencing serum neurofilament light chain levels in normal ageing
18. Jahrestagung der Österreichischen Gesellschaft für Neurologie; APR 9-10, 2021; Tulln, AUSTRIA. 2021. [Onlinepräsentation]

 

Koini, M; Pirpamer, L; Hofer, E; Buchmann, A; Pinter, D; Ropele, S; Enzinger, C; Benkert, P; Leppert, D; Kuhle, J; Schmidt, R; Khalil, M; Confounding factors of serum neurofilament light levels in normal ageing
7th Congress of the European Academy of Neurology - Virtual 2021; JUN 19-22, 2021; Vienna, AUSTRIA. 2021. [Onlinepräsentation]

 

Lazzarotto, A; Hamzaoui, M; Tonietto, M; Ricigliano, VAG; Boffa, G; Khalil, M; Pirpamer, L; Ropele, S; Enzinger, C; Battaglini, M; Stromillo, ML; De Stefano, N; Rocca, MA; Gallo, P; Gasperini, C; Stankoff, B; Bodini, B Cortical remyelination predicts cortical atrophy and clinical progression in early multiple sclerosis
MULT SCLER J. 2021; 27(2_SUPPL):116-117.-ECTRIMS; Vienna, Austria. [Oral Communication]
Web of Science

 

Pirpamer, L; Hofer, E; Buchmann, A; Pinter, D; Ropele, S; Enzinger, C; Benkert, P; Leppert, D; Kuhle, J; Schmidt, R; Khalil, M; Koini, M Factors influencing serum neurofilament light chain levels in normal ageing
EUR J NEUROL. 2021; 28: 256-256.-EAN Virtual; [Oral Communication]
Web of Science

 

Buchmann, A; Pirpamer, L; Pinter, D; Voortman, M; Helmlinger, B; Pichler, A; Bachmaier, G; Ropele, S; Enzinger, C; Fazekas, F; Khalil, M Serum neurofilament light levels correlate with reduced grey matter volume in advanced multiple sclerosis.
17. Jahrestagung der ÖGN; SEP 20- 21, 2020; Salzburg, AUSTRIA. 2020. [Poster]

 

Buchmann, A; Pirpamer, L; Pinter, D; Voortman, M; Helmlinger, B; Pichler, A; Bachmaier, G; Ropele, S; Enzinger, C; Fazekas, F; Khalil, M P0156 - Serum neurofilament light levels correlate with reduced grey matter volume in advanced multiple sclerosis.
MSVirtual (ACTRIMS/ECTRIMS joint meeting); SEP 15, 2020; Washington, DC, USA. 2020. [Poster]

 

Buchmann, A; Pirpamer, L; Pinter, D; Voortman, M; Helmlinger, B; Pichler, A; Bachmaier, G; Ropele, S; Enzinger, C; Khalil, M Serum neurofilament light levels correlate with reduced grey matter volume in advanced multiple sclerosis.
MULT SCLER J. 2020; 26(3_SUPPL):192-193.-8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual); SEP 11-13, 2020; ELECTR NETWORK. [Onlinepräsentation]
Web of Science

 

Buchmann, A; Pirpamer, L; Voortman, M; Pinter, D; Pichler, A; Bachmaier, G; Ropele, S; Enzinger, C; Fazekas, F; Khalil, M #2630 Serum Neurofilament Light Correlates with Reduced Grey Matter Volume in Advanced Multiple Sclerosis.
European Journal of Neurology, May 2020. 2020; 27(Suppl1):45-45.-6th EAN Congress; MAY 23-25, 2020 ; Paris, FRANCE. [Oral Communication]
Web of Science FullText

 

Colonna, I; Buchmann, A; Damulina, A; Pinter, D; Helmlinger, B; Pirpamer, L; Soellradl, M; Tinauer, C; Ropele, S; Enzinger, C; Schmidt, R; Khalil, M Comparison of deep grey matter iron deposition assessed by 3t mri r2(star) relaxometry in multiple sclerosis, alzheimer´s disease and in normal controls.
MULT SCLER J. 2020; 26(3_SUPPL):659-659.-8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual); SEP 11-13, 2020; ELECTR NETWORK. [Onlinepräsentation]
Web of Science

 

Gassner, B; Pinter, D; Khalil, M; Heschl, B; Fuchs, S; Pichler A; Enzinger, C Untersuchungen zur Bedeutung des Timed 25-Foot Walk Test als Maß der Gangbeeinträchtigung bei Multipler Sklerose.
17. Jahrestagung der österreichischen Gesellschaft für Neurologie; SEP 20-21, 2020; Vienna, AUSTRIA. 2020. [Poster]

 

Hechenberger, S; Pinter, D; Helmlinger, B; Pichler, A; Khalil, M; Enzinger, C Processing speed improves prediction of physical impairment in patients with multiple sclerosis.
MULT SCLER J. 2020; 26(3_SUPPL):509-510.-8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual); SEP 11-13, 2020; ELECTR NETWORK. [Poster]
Web of Science

 

Helmlinger, B; Pinter, D; Ropele, S; Pirpamer, L; Khalil, M; Enzinger, C Multimodal mri of the brain to improve prediction of disease progression in multiple sclerosis.
MULT SCLER J. 2020; 26(3_SUPPL):409-409.-8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual); SEP 11-13, 2020; ELECTR NETWORK. [Onlinepräsentation]
Web of Science

 

Helmlinger, B; Pinter, D; Ropele, S; Pirpamer, L; Khalil, M; Enzinger C Multimodal MRI to Improve Prediction of Disease Progression in Multiple Sclerosis.
MSVirtual 2020. Joint ACTRIMS-ECTRIMS Meeting; SEP 11-13, 2020; Washington, USA. 2020. [Poster]

 

Khalil, M Prognostische Liquormarker bei Multipler Sklerose und immunmediierten ZNS-Erkrankungen.
Liquor-Symposium 2020 – Aktuelles und Neues in der Liquordiagnostik, Universität Spital Zürich; NOV 24, 2020; Zurich, Switzerland. 2020. [Oral Communication]
FullText

 

Khalil, M Neue Entwicklungen der Biomarkerforschung bei entzündlich-demyelinisierenden und degenerativen ZNS-Erkrankungen.
Neurologischer Donnerstag - Neuromed Campus, Kepler Universitätsklinikum; OCT 1, 2020; Linz . 2020. [Oral Communication]
FullText

 

Khalil, M Was wir aus Real-World-Evidence-Daten lernen können.
RWE Veranstaltung Salzburg; DEC, 2, 2020; Salzburg, AUSTRIA. 2020. [Oral Communication]

 

Khalil, M Dynamik von Liquorveränderungen, Erregerdiagnostik.
ÖGN FACHÄRZTINNENAUSBILDUNGSSEMINAR; DEC 3-4, 2020; Graz, AUSTRIA. 2020. [Oral Communication]

 

Khalil, M Neurologische Erkrankungen als Folge von Immuntherapien.
ÖGN FACHÄRZTINNENAUSBILDUNGSSEMINAR; Dec 3-4-, 2020; Graz, Austria. 2020. [Oral Communication]

 

Khalil, M Autoimmunerkrankungen des ZNS.
ÖGN FACHÄRZTINNENAUSBILDUNGSSEMINAR; DEC 3-4, 2020; Graz, Austria. 2020. [Oral Communication]

 

Khalil, M Real World Evidence Daten - Stellenwert in der MS Forschung.
17. Jahrestagung der Österreichischen Gesellschaft für Neurologie.; SEP 20-21, 2020; Salzburg, AUSTRIA. 2020. [Oral Communication]
FullText

 

Khalil, M Serologische und Liquor Biomarker.
17. Jahrestagung der Österreichischen Gesellschaft für Neurologie.; SEP 20-21, 2020; Salzburg, AUSTRIA. 2020. [Oral Communication]
FullText

 

Pinter, D; Fruhwirth, V; Kober, S; Khalil, M; Neuper, C; Wood, G; Enzinger, C MRI correlates of cognitive improvement after home-based EEG neurofeedback training in MS: a pilot study.
MULT SCLER J. 2020; 26(3_SUPPL):32-32.-8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual); SEP 11-13, 2020; ELECTR NETWORK. [Oral Communication]
Web of Science

 

Bsteh, G; Berek, K; Hegen, H; Teuchner, B; Auer, M; Wurth, S; Zinganell, A; Di Pauli, F; Deisenhammer, F; Khalil, M; Berger, T Serum neurofilament light chain levels correlate with peripapillary retinal nerve fibre layerthinning as measured by optical coherence tomography in multiple sclerosis
MULT SCLER J. 2019; 25: 109-110.-35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS; SEP 11-13, 2019; Stockholm, SWEDEN. [Oral Communication]
Web of Science

 

Buchmann, A; Pirpamer, L; Voortman, M; Pichler, A; Bachmaier, G; Ropele, S; Enzinger, C; Fazekas, F; Khalil, M Serum Neurofilament light correlates with reduced grey matter volume in advancing multiple sclerosis.
Doctoral Day 2019; 21.11.2019; Graz, AUSTRIA. 2019. [Poster]
FullText

 

Buchmann, A; Pirpamer, L; Voortman, M; Pichler, A; Bachmaier, G; Ropele, S; Enzinger, C; Fazekas, F; Khalil M Serum Neurofilament light correlates with reduced grey matter volume in advancing multiple sclerosis.
47th Annual Meeting of the Austrian Society for Allergology and Immunology (ÖGAI); NOV 21-23, 2019; Graz, AUSTRIA. 2019. [Poster]
FullText

 

Khalil, M Neue Methoden in der Liquordiagnostik im Rahmen der ARGE Sitzung Neuroimmunologie, Liquordiagnostik, Neuroonkologie.
16. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 20-22, 2019; Eisenstadt, AUSTRIA. 2019. [Oral Communication]

 

Khalil, M sNFL in Stroke and Normal Aging
Simoa® Symposium at NMI; JUL 16, 2019; Reutlingen, GERMANY. 2019. [Oral Communication]

 

Khalil, M Liquor und andere Biomarker bei MS und anderen Autoimmunerkrankungen – was müssen KlinikerInnen wissen?
MS Akademie 2019; SEP 27-28, 2019; 2019. [Oral Communication]
FullText

 

Khalil, M Update Neurofilamente in Liquor und Serum im Rahmen der ARGE Sitzung Neuroimmunologie, Liquordiagnostik, Neuroonkologie.
16. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 20-22, 2019; Eisenstadt, AUSTRIA. 2019. [Oral Communication]

 

Khalil, M Liquordiagnostik: Neues zu Aß42, Tau, Neurofilament Leichtketten & Co
32. Jahrestagung der Österreichischen Alzheimer-Gesellschaft ; SEP 20-21,2019; Gars/Thunau, AUSTRIA. 2019. [Oral Communication]
FullText

 

Khalil, M Neurofilaments as Biomarkers in Neurological Disorders
Local Chapter Graz - "Horizon Scanning Neuroscience Austria". AUSTRIAN NEUROSCIENCE ASSOCIATION ÖSTERREICHISCHE GESELLSCHAFT FÜR NEUROWISSENSCHAFTEN, Inge.st Initiative Gehirnforschung Steiermark.; FEB 28, 2019; Graz, AUSTRIA. 2019. [Oral Communication]

 

Khalil, M. Assessment kognitiver Funktionen bei allen MS-PatientInnen bereits zum Zeitpunkt der Diagnose: PRO
18. Workshop der DIFFERENTIALDIAGNOSEN DER MS; MAY 18, 2019; Graz, AUSTRIA. 2019. [Oral Communication]

 

Khalil, M. Quantitative IgG Synthese vs. freie Leichtketten
Jahrestagung der DGLN - Deutsche Gesellschaft für Liquordiagnostik und Klinische Neurochemie e.V. (DGLN); MAY 24-25, 2019; Münster, GERMANY. 2019. [Oral Communication]

 

Khalil, M. The Role of Serum Neurofilament light in MS
Biogen MS Science Chats at EAN; JUL 1, 2019; Oslo, NORWAY. 2019. [Oral Communication]

 

Khalil, M; Pirpamer, L; Hofer, E; Voortman, M; Barro, C; Leppert, D; Benkert, P; Ropele, S; Enzinger, C; Fazekas, F; Schmidt, R; Kuhle, J Serum neurofilament light levels in normal aging: associations with morphologic brain changes
EUR J NEUROL. 2019; 26: 17-18. [Oral Communication]
Web of Science

 

Khalil, M; Pirpamer, L; Hofer, E; Voortman, MM; Barro, C; Ropele, S; Enzinger, C; Fazekas, F; Schmidt, R; Kuhle, J Serum neurofilament light levels in normal aging: associations with morphologic brain changes.
16. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 20-22, 2019; Eisenstadt, AUSTRIA. 2019. [Poster]

 

Pinter, D; Khalil, M; Pirpamer, L; Damulina, A; Fruhwirth, V; Pichler, A; Fuchs, S; Fazekas, F; Enzinger, C Long-term course of cognitive function and disability in patients with MS.
8th Annual Meeting of the International MS Cognition Society; JUN 6-7, 2019; Amsterdam, THE NETHERLANDS. 2019. [Poster]

 

Pinter, D; Khalil, M; Pirpamer, L; Damulina, A; Fruhwirth, V; Pichler, A; Fuchs, S; Fazekas, F; Enzinger, C The evolution of cognitive function in MS over ten years and the association with MRI findings
MULT SCLER J. 2019; 25: 400-401.-35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS; SEP 11-13, 2019; Stockholm, SWEDEN. [Oral Communication]
Web of Science

 

Pinter, D; Khalil, M; Pirpamer, L; Damulina, A; Fruhwirth, V; Pichler, A; Fuchs, S; Fazekas, F; Enzinger, C Diagnosis and monitoring of MS associated neurocognitive disorder: tests, assessment tools, computer interface etc
MULT SCLER J. 2019; 25(8):NP12-NP12.-Annual Meeting of the International-Multiple-Sclerosis-Cognition-Society (IMSCOGS); JUN 06-07, 2019; Amsterdam, NETHERLANDS. [Oral Communication]
Web of Science

 

Pinter, D; Khalil, M; Pirpamer, L; Damulina, A; Fruhwirth, V; Pichler, A; Fuchs, S; Fazekas, F; Enzinger C The evolution of cognitive function in MS over ten years and the association with MRI findings
ECTRIMS Congress App. 2019; -ECTRIMS; SEP 11-13, 2019; Stockholm, SWEDEN. [Poster]

 

Stryeck, S; Voortman, M; Enzinger, C; Fuchs, S; Deisenhammer, F; Hegen, H; Fazekas, F; Madl, T; Khalil, M Serum NMR spectroscopy metabolomic profiles indicate progressive multiple sclerosis
EUR J NEUROL. 2019; 26: 241-241. [Poster]
Web of Science

 

Hallwirth, F; Moser, D; Voortman, M; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, H; Fazekas, F; Khalil, M Immunomodulatory therapy reduces elevated serum nitric oxide levels in multiple sclerosis patients.
Neurologisch. 2018; 2018(S1):63-63.-15. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 21-23, 2018; Linz, AUSTRIA. [Poster]
FullText

 

Hallwirth, F; Moser, D; Voortman, M; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, HJ; Fazekas, F; Khalil, M Immunomodulatory therapy reduces elevated nitric oxide levels in multiple sclerosis patients
EUR J NEUROL. 2018; 25: 254-254.-4th Congress of the European Academy of Neurology (EAN); JUN 16-19, 2018; Lisbon, PORTUGAL. [Poster]
Web of Science

 

Hallwirth, F; Moser, D; Voortman, MM; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, H; Fazekas, F; Khalil, M Serum nitric oxide is increased in untreated in multiple sclerosis patients.
Abstract book CSF Society. 2018; 26. – Abstracts of the 2nd Meeting of the Society for CSF analysis and clinical neurochemistry (CSF Society); June 7-8, 2018; Amsterdam, The Netherlands. [Poster and Abstract].. 2018; 26-26.-2nd Meeting of the Society for CSF analysis and clinical neurochemistry; JUN 7-8, 2018; Amsterdam, THE NETHERLANDS. [Poster]
FullText

 

Hallwirth, F; Moser, D; Voortman, M.M; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, H-J; Fazekas, F; Khalil M Immunomodulatory therapy reduces elevated NOX levels in multiple sclerosis patients
2nd Meeting of the Society for CSF analysis and clinical neurochemistry ; JUN 7-8, 2018; Amsterdam. 2018. [Poster]
FullText

 

Khalil, M Current approaches to MS research in Graz
European Charcot Foundation webinar; FEB 05, 2018; 2018. [Oral Communication]
FullText

 

Khalil, M Autoimmunerkrankungen des ZNS
ÖGN FACHARZTAUSBILDUNGSSEMINAR; NOV 22-24, 2018; Graz, AUSTTRIA. 2018. [Oral Communication]

 

Khalil, M Laborchemische Beurteilung des MS Verlaufs: sind wir bald soweit?
17. Workshop der DIFFERENTIALDIAGNOSEN der MS; MAY 4, 2018; Graz, AUSTRIA. 2018. [Oral Communication]

 

Khalil, M Neuroimmunologische Erkrankungen – Labordiagnostik
MS Insights - Multiple Sklerose und andere neuroimmunologische Erkrankungen ; APR 13-14, 2018; Vienna, AUSTRIA. 2018. [Keynote lecture]

 

Khalil, M Dynamik von Liquorveränderungen, Erregerdiagnostik
ÖGN FACHARZTAUSBILDUNGSSEMINAR; NOV 22-24, 2018; Graz, AUSTRIA. 2018. [Oral Communication]

 

Khalil, M NeurologischeErkrankungen als Folge von Immuntherapien
ÖGN FACHARZTAUSBILDUNGSSEMINAR; NOV 22-24, 2018; Graz, AUSTRIA. 2018. [Oral Communication]

 

Khalil, M Other MRI project options
International Multiple Sclerosis Genetics Consortium Meeting; OCT 9, 2018; Berlin, GERMANY. 2018. [Oral Communication]

 

Khalil, M Research update on body fluid biomarkers in neurological disorders
Regional Neurophysiology and Neurology Meeting (Graz – Ljubljana – Trieste – Zagreb) with the 34th Dr. Janez Faganel Memorial Lecture; SEP 28, 2018; Ljubljana, SLOVENIA. 2018. [Oral Communication]

 

Khalil, M Neuroimmunologische Bedeutung von Biomarkern
MS in a BOX - NEUROIMMUNOLOGIE; NOV 29-30; Vienna, AUSTRIA. 2018. [Oral Communication]

 

Khalil, M Intrathekale IgG-Synthese vs. freie Leichtketten
Symposium der DGLN: Aktuelle Entwicklungen zu Biomarkern in der Labordiagnostik ; NOV 2, 2018; Berlin, GERMANY. 2018. [Oral Communication]

 

Khalil, M Update MS Society Study
Neuroimage WING / BIG WIG MS Meeting; OCT 18, 2018; Graz, AUSTRIA. 2018. [Oral Communication]

 

Khalil, M Bedeutung der Liquordiagnostik in der Differenzialdiagnose entzündlich-demyelinisierender ZNS Erkrankungen.
15. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN). ARGE Neuroonkologie / Liquordiagnostik / Neuroimmunologie.; MAR 21-23, 2018; Linz, AUSTRIA. 2018. [Oral Communication]

 

Khalil, M; Pirpamer, L; Hofer, E; Voortman, MM; Hallwirth, F; Barro, C; Fazekas, F; Schmidt, R; Kuhle, J Normative values of serum neurofilament light levels
Multiple Sclerosis Journal, ECTRIMS 2018. 2018; 24(S2):657-658.-34th Congress of the European Committee for Treatment and Research of Multiple Sclerosis (ECTRIMS); OCT 10-12, 2018; Berlin, GERMANY. [Poster]
Web of Science FullText

 

Kuhle, J; Barro, C; Hrusovsky, K; Chang, L; Jeromin, A; Bridel, C; Bar-Or, A; Bittner, S; Bruck, W; Bielekova, B; Chitnis, T; Comi, G; Comabella, M; Arrambide, G; Montalban, X; Datwani, A; Fluck, M; Fox, R; Freedman, M; Furlan, R; Gnanapavan, S; Giovannoni, G; Havari, E; Khalil, M; Leppert, D; Kropshofer, H; Valentin, MA; Oksenberg, J; Piehl, F; Plavina, T; Sormani, MP; Lehmann, S; Thouvenot, E; Ziemssen, T; Zipp, F; Gross, C; Wiendl, H; Kappos, L; Michalak, Z; Blennow, K; Zetterberg, H; Teunissen, C; Wilson, D International multi-site analytical validation of the Simoa NF-light assay in human serum samples from multiple sclerosis patients
MULT SCLER J. 2018; 24: 249-251.-34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 10-12, 2018; Berlin, GERMANY. [Poster]
Web of Science

 

Pichler, A; Hochstrasser, D; Khalil, M; Langkammer, C; Pirpamer, L; Pinter, D; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F The effect of smoking on 'normal appearing white matter' and lesion load in periventricular regions of patients with multiple sclerosis
MULT SCLER J. 2018; 24: 582-582. [Poster]
Web of Science

 

Schoonheim, MM; Pinter, D; Meijer, KA; Eijlers, AJC; Pirpamer, L; Khalil, M; Pichler, A; Fuchs, S; Fazekas, F; Uitdehaag, BMJ; Barkhof, F; Enzinger, C; Geurts, JJG Specific patterns of thalamic functional connectivity changes related to disability and cognitive impairment in multiple sclerosis
MULT SCLER J. 2018; 24: 613-614. [Poster]
Web of Science

 

Voortman, MM; Greiner, P; Moser, D; Stradner, MH; Graninger, W; Moser, A; Haditsch, B; Enzinger, C; Fuchs, S; Fazekas, F; Fessler, J; Khalil, M The effect of disease modifying therapies on CD62L expression in multiple sclerosis.
Multiple Sclerosis Journal, ECTRIMS 2018. 2018; 24(S2):255-255.-34th Congress of the European Committee for Treatment and Research of Multiple Sclerosis (ECTRIMS); OCT 10-12, 2018; Berlin, GERMANY. [Poster]
Web of Science FullText

 

Voortman, MM; Greiner, P; Moser, D; Stradner, MH; Graninger, W; Moser, A; Haditsch, B; Enzinger; C; Fuchs, S; Fazekas, F; Fessler, J; Khalil, M The effect of disease modifying treatment on CD62L expression in multiple sclerosis
Abstract book Doctoral Day Retrain the Brain 2018. 2018; 64-64.-Doctoral Day Retrain the Brain; NOV 28, 2018; Graz, AUSTRIA. [Poster]
FullText

 

Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, J-J; Fazekas, F; Marsche, G; Khalil, M Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Abstract book 2nd Meeting of the Society for CSF analysis and clinical neurochemistry. 2018; 73-73.-2nd Meeting of the Society for CSF analysis and clinical neurochemistry; JUN 7-8, 2018; Amsterdam, THE NETHERLANDS. [Poster]
FullText

 

Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, JJ; Fazekas; Marsche, G; Khalil, M Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Neurologisch. 2018; 2018(S1):61-61.-15. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 21-23, 2018; Linz, AUSTRIA. [Poster]
FullText

 

Borsodi, F; Culea, V; Langkammer, C; Khalil, M; Pirpamer, L; Quasthoff, S; Enzinger, C; Fazekas, F; Ropele, S No Evidence of Increased Iron Accumulation in the Deep Gray Matter of Patients with Amyotrophic Lateral Sclerosis (ALS).
Proceedings of the 23rd Annual Meeting ISMRM 2017. 2017; -25th Annual Meeting ISMRM 2017; APR 22-27, 2017; Honolulu, HI, USA. [Poster]

 

Fissolo, N; Issazadeh-Navikas, S; Dujmovic, I; Voortman, MM; Khalil, M; Montalban, X; Comabella, M. Serpina3n: potential biomarker in patients with progressive multiple sclerosis.
Multiple Sclerosis Journal. 2017; 23(S3):219-219.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting ; OCT 25-28, 2017; Paris, FRANCE. [Poster]
Web of Science FullText

 

Gattringer, T; Pinter, D; Enzinger, C; Kneihsl, M; Fandler, S; Pichler, A; Barro, C; Grobke, S; Voortman, M; Seifert-Held, T; Pirpamer, L; Hofer, E; Ropele, S; Schmidt, R; Kuhle, J; Fazekas, F; Khalil, M Serum neurofilament light chain protein: A promising biomarker for lacunar stroke and cerebral small vessel disease.
EUR J NEUROL. 2017; 24: 462-462.-3rd Congress of the European Academy of Neurology (EAN); JUN 24-27, 2017; Amsterdam, THE NETHERLANDS. [Oral Communication]
Web of Science

 

Gattringer, T; Pinter, D; Enzinger, C; Seifert-Held, T; Kneihsl, M; Fandler, S; Pichler, A; Barro, C; Gröbke, S; Voortman, M; Pirpamer, L; Hofer, E; Ropele, S; Schmidt, R; Kuhle, J; Fazekas, F; Khalil, M Serum neurofilament light chain protein: A promising biomarker for lacunar stroke and cerebral small vessel disease.
European Stroke Journal. 2017; 2(IS):227-227.-3rd European Stroke Organisation Conference; MAY 16-18, 2017; Prague, Czech Republic. [Poster]
FullText

 

Hallwirth, F; Moser, D; Voortman, MM; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, H-J; Fazekas; Khalil, M Serum nitric oxide is increased in untreated multiple sclerosis patients.
Mult Scler J. 2017; 23(S3):586-587.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting ; OCT 25-28, 2017; Paris, FRANCE. [Poster]
Web of Science

 

Hegen, H; Khalil, M Crash-Kurs Liquordiagnostik
14. JAHRESTAGUNG DER ÖSTERREICHISCHEN GESELLSCHAFT FÜR NEUROLOGIE; MAR 22-24, 2017; Villach, AUSTRIA. 2017. [Oral Communication]

 

Khalil, M Differentialdiagnosen der MS: „Progrediente MS und neue Diagnosekriterien“ - Biomarker am Horizont?
16. Workshop der Differentialdiagnosen der Multiplen Sklerose; MAY 6, 2017; Graz. 2017. [Oral Communication]

 

Khalil, M „Progressive Krankheitsheitsverläufe – Management entlang von Definitionen und Indikatoren“ - Biomarker bei chronisch progredienten MS Verlaufsformen?
ÖGN, 14. JAHRESTAGUNG DER ÖSTERREICHISCHEN GESELLSCHAFT FÜR NEUROLOGIE. Gemeinsame Sitzung der AG Neuroimmunologie / ARGE Neuro-Labordiagnostik / ARGE NMO / AG Neuroonkologie ; MAR 22, 2017 ; Villach, AUSTRIA. 2017. [Oral Communication]

 

Khalil, M Quantitatve IgG-Synthese versus Freie Leichtketten
Jahrestagung der DGLN; MAY 12-13,2017; Heidelberg, GERMANY. 2017. [Oral Communication]

 

Khalil, M Monitoring der MS - Monitoring anhand des Labors
MS Akademie; 29-30 SEP, 2017; Mondsee, AUSTRIA. 2017. [Oral Communication]

 

Khalil, M HOW TO MONITOR DISEASE EVOLUTION AND TREATMENT - Body fluids
25th Annual Meeting European Charcot Foundation; NOV 30 - DEC 02; Baveno, ITALY. 2017. [Oral Communication]

 

Khalil, M Neurologische Biomarker
Neuroscience Local Chapter Graz; JAN 24, 2017; Graz. 2017. [Oral Communication]

 

Khalil,M Laboruntersuchungen zur Differentialdiagnostik der Multiplen Sklerose
Neuroscience in Motion 2017; NOV 10-11, 2017; Vienna. 2017. [Oral Communication]

 

Leurs CE; Twaalfhoven, HAM; Witte, BI; Van Pesch, V; Dujmovic, I; Drulovic, J; Castellazzi, M; Bellini, T; Pugliatti, M; Kuhle, J; Villar, LM; Alvarez Cermeño, JC; Alvarez-Lafuente, R; Hegen, H; Deisenhammer, F; Thouvenot, E; Comabella, M; Montalban, X; Vécsei, L; Rajda, C; Galimberti, D; Altintas, A; Rejdak, K; Frederiksen, JL; Pihl-Jensen, G; Jensen, PE; Khalil, M; Voortman, MM; Fazekas, F; Saiz, A; La Puma, D; Vercammen, MJ; VanopdenBosch, L; Uitdehaag, BMJ; Killestein, J; Teunissen, C. Kappa free light chains: an automated alternative to oligoclonal bands for CIS and MS diagnosis?
Multiple Sclerosis Journal. 2017; 23(S3):591-592.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting ; OCT 25-28, 2017; Paris, FRANCE. [Poster]
Web of Science FullText

 

Pinter, D; Beckmann, C; Fazekas, F; Khalil, M; Pichler, A; Ropele, S; Fuchs, S; Enzinger, C Morphologic MRI phenotyping of multiple sclerosis associates with altered brain function
MULT SCLER J. 2017; 23: 539-540. [Poster]
Web of Science

 

Pinter, D; Fazekas, F; Damulina, A; Pirpamer, L; Pichler, A; Khalil, M; Ropele, S; Fuchs, S; Enzinger, C Evolution of cognitive function in MS and its relationship to physical disability and MRI metrics
MULT SCLER J. 2017; 23: 285-286. [Poster]
Web of Science

 

Pinter, D; Pirpamer, L; Damulina, A; Fazekas, F; Pichler, A; Khalil, M; Fuchs, S; Enzinger, C Long-term course of cognitive function and disability in patients with MS
MULT SCLER J. 2017; 23(8): NP1-NP1. [Oral Communication]
Web of Science

 

Voortman, M; Pekar, T; Bachmayer, D; Archelos-Garcia, JJ; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Seifert-Held, T; Khalil, M The role of serum netrin-1 in early multiple sclerosis.
EUR J NEUROL. Eur J Neurol 2017; 24 (Suppl 1). 2017; 24: 313-313.-3rd Congress of the European Academy of Neurology (EAN); JUN 24-27, 2017; Amsterdam, THE NETHERLANDS. [Poster]
Web of Science FullText

 

Voortman, MM; Pekar, T; Bachmayer D; Archelos, JJ; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Seifert-Held, T; Khalil, M The role of serum netrin-1 in early multiple sclerosis.
Neurologisch. 2017; 2017(S2):50-51.-14. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); Mar 22-24, 2017; Villach, Austria; MAR 22-24, 2017; Villach, AUSTRIA. [Oral Communication]

 

Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, JJ; Fazekas, F; Marsche, G; Khalil, M Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Multiple Sclerosis Journal. 2017; 23(S3):303-304.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting; OCT 25-28, 2017; Paris, FRANCE. [Poster]
Web of Science FullText

 

Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, JJ; Fazekas, F; Marsche, G; Khalil, M Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Doctoral day of the Medical University of Graz; DEC 13, 2017; Graz, AUSTRIA. 2017. [Oral Communication]

 

Gattringer, T; Khali,l M; Langkammer, C; Jehna, M; Pichler, A; Pinter, D; Kneihsl, M; Petrovic, K; Ropele, S; Fazekas, F; Enzinger, C No evidence for increased brain iron deposition in patients with ischemic white matter disease.
European Journal of Neurology 2016. 2016; -2nd CONGRESS OF THE EUROPEAN ACADEMY OF NEUROLOGY; MAY 28-31; COPENHAGEN. [Oral Communication]
FullText

 

Khalil, M IEF oligoclonal bands or quantification of total light chains – what is the status?
The 1st Meeting OF the Society for CSF analysis and Clinical Neurochemistry; MAY 12-13; GOTHENBURG. 2016. [Oral Communication]

 

Khalil, M Current approaches to MS research in Graz
BIG-WIG (Bildgebung, Immunpathogenese, Gesundungsfaktoren – Wien, Innsbruck, Graz – bei Multiple Sklerose’; ‘Neuroimaging, immunopathogenesis and salutogenic factors in MS – a collaborative effort of the universities of Vienna, Innsbruck and Graz’) symposium; Nov 22; Vienna, AUSTRIA. 2016. [Oral Communication]

 

Khalil, M Iron metabolism and determinants of iron accumulation in MS
Proceedings of the 4th International Workshop on MRI Phase Contrast & Quantitative Susceptibility Mapping. 2016; -4th International Workshop on MRI Phase Contrast & Quantitative Susceptibility Mapping; SEP 26-28; Graz, AUSTRIA. [Oral Communication]

 

Khalil, M; Hegen, H Liquor-Crashkurs
13. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN) mit Fortbildungsakademie; MAR 16-18; Innsbruck, AUSTRIA. 2016. [Oral Communication]

 

Kneihsl, M; Enzinger, C; Wünsch, G; Khalil, M; Culea, V; Urbanic-Purkart, T; Payer, F; Niederkorn, K; Fazekas, F; Gattringer, T Poor short-term outcome in patients with ischemic stroke and active cancer
19. Jahrestagung der Österreichischen Schlaganfall-Gesellschaft; JAN, 21-23, 2016; Krems, AUSTRIA. 2016. [Oral Communication]

 

Moser, A;Spindelboeck, W;Strohmaier, H; Enzinger, C; Gattringer, T; Fuchs, S; Fazekas, F; Gorkiewicz, G; Wurm, P; Högenauer, C; Khalil, M Mucosal biopsy reveals immunologic changes of the colon in patients with early multiple sclerosis.
32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis. 2016; -ECTRIMS; SEP 14-17; London, UK. [Poster]

 

Pichler, A; Khalil, M; Langkammer, C; Pinter, D; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F The impact of cardiovascular comorbidities on the temporal evolution of brain volume and lesion load in early multiple sclerosis.
MULT SCLER J. 2016; 22: 70-70.-32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); SEP 14-17, 2016; London, ENGLAND. [Oral Communication]
Web of Science

 

Pichler, A; Khalil, M; Langkammer, C; Pinter, D; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F The impact of cardiovascular comorbidities on the temporal evolution of brain volume and lesion load in patients with early MS.
32nd congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); Sep 14-17, 2016; London, UK. 2016. [Oral Communication]

 

Pinter, D; Khalil, M; Greiner, P; Moser, D; Koini, M; Pirker, E; Pichler, A; Bachmaier, G; Fuchs, S; Fazekas, F; Enzinger, C The relationship between resting-state connectivity alterations and the extent of focal white matter lesion changes in multiple sclerosis.
The 5th biennial conference on resting-state brain connectivity; SEP 21-23, 2016; Vienna, AUSTRIA. 2016. [Poster]

 

Pinter, D; Khalil, M; Greiner, P; Moser, D; Koini, M; Pirker, E; Pichler, A; Bachmaier, G; Fuchs, S; Fazekas, F; Enzinger, C The relationship between resting-state connectivity alterations and the extent of focal white matter lesion changes in multiple sclerosis.
32st Congress of the European Committee for Treatment and Research in Multiple Sclerosis; SEP 14-17, 2016; London, UK. 2016. [Poster]

 

Pinter, D; Khalil, M; Greiner, P; Moser, D; Koini, M; Pirker, E; Pichler, A; Bachmaier, G; Ropele, S; Fuchs, S; Fazekas, F; Enzinger, C The relationship between resting-state connectivity alterations and the extent of focal white matter lesion changes in multiple sclerosis
MULT SCLER J. 2016; 22: 759-759.
Web of Science

 

Pinter, D; Khalil, M; Greiner, P; Moser, D; Pirker, E; Pichler, A; Bachmaier, G; Ropele, S; Fuchs, S; Fazekas, F; Enzinger, C Lesion filling more strongly affects estimation of grey than white matter volumes in a large patient sample depending on hyperintense lesion load
MULT SCLER J. 2016; 22: 512-512.
Web of Science

 

Spindelboeck, W; Moser, AM; Strohmaier, H; Enzinger, C; Gattringer, T; Fuchs, S; Fazekas, F; Gorkiewicz, G; Wurm, P; Hogenauer, C; Khalil, M Mucosal biopsy reveals immunologic changes of the colon in patients with early multiple sclerosis
MULT SCLER J. 2016; 22: 179-179.
Web of Science

 

Voortman, M; Bachmayer, D; Seifert-Held, T; Archelos, JJ; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Khalil, M No association of serum Netrin-1 with MRI based evidence of disease activity in early multiple sclerosis.
MULT SCLER J. 2016; 22: 274-274.-32nd Congress of the European Committee for Treatment and Research in Multiple-Sclerosis (ECTRIMS); SEP 14-17, 2016; London, UNITED KINGDOM. [Poster]
Web of Science

 

Voortman, MM; Bachmayer, D; Pekar, T; Seifert-Held, T; Archelos, J-J; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Khalil, M The role of serum Netrin-1 in early multiple sclerosis.
Doctoral day Medical University of Graz; DEC 14, 2016; Graz, AUSTRIA. 2016. [Oral Communication]

 

Voortman, MM; Bachmayer, D; Seifert-Held, T; Archelos, JJ; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Khalil, M No association of serum Netrin-1 with MRI based evidence of disease activity in early multiple sclerosis.
Multiple Sclerosis Journal. 2016; 22(S3):274-274.-32nd congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); SEP 14-17, 2016; London, UNITED KINGDOM. [Poster]
FullText

 

Voortman, MM; Bachmayer, D; Seifert-Held, T; Archelos, JJ; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Khalil, M The role of serum Netrin-1 in early multiple sclerosis.
BIG-WIG (Bildgebung, Immunpathogenese, Gesundungsfaktoren – Wien, Innsbruck, Graz – bei Multiple Sklerose’; ‘Neuroimaging, immunopathogenesis and salutogenic factors in MS – a collaborative effort of the universities of Vienna, Innsbruck and Graz’) symposium; NOV 22, 2016; Vienna, AUSTRIA. 2016. [Oral Communication]
FullText

 

Voortman, MM; Stojakovic, T; Pirpamer, L; Jehna, M; Langkammer, C; Scharnagl, H; Reindl, M; Ropele, S; Seifert-Held, T; Archelos, J-J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
BIG-WIG (Bildgebung, Immunpathogenese, Gesundungsfaktoren – Wien, Innsbruck, Graz – bei Multiple Sklerose’; ‘Neuroimaging, immunopathogenesis and salutogenic factors in MS – a collaborative effort of the universities of Vienna, Innsbruck and Graz’) symposium; NOV 22, 2016; Vienna, AUSTRIA. 2016. [Oral Communication]
FullText

 

Gattringer, T; Enzinger, C; Fischer, R; Seyfang, L; Niederkorn, K; Khalil, M; Ferrari, J; Lang, W; Brainin, M; Willeit, J; Fazekas, F Intravenöse Thrombolyse bei PatientInnen mit ischämischem Schlaganfall und Alkoholabusus
18. Jahrestagung der Österreichischen Schlaganfall Gesellschaft; JAN, 22-24, 2015; Feldkirch. 2015. [Oral Communication]
FullText

 

Gattringer, T; Enzinger, C; Fischer, R; Seyfang, L; Niederkorn, K; Khalil, M; Ferrari, J; Lang, W; Brainin, M; Willeit, J; Fazekas, F Intravenöse Thrombolyse bei PatientInnen mit ischämischem Schlaganfall und Alkoholabusus
32. Jahrestagung der Arbeitsgemeinschaft für Neurointensivmedizin (ANIM); JAN, 29-31, 2015; Berlin. 2015. [Oral Communication]
FullText

 

Gattringer, T; Kneihsl, M; Enzinger, C; Wünsch, G; Khalil, M; Uranic-Purkart, T; Payer, F; Niederkorn, K; Fazekas, F Poor short-term outcome in patients with ischemic stroke and active cancer.
Special Issue: Abstracts of the 1st Congress of the European Academy of Neurology, Berlin, Germany, June 2015. European Journal of Neurology.. 2015; 228-228.-First congress of the European Academy of Neurology; June 20-23, 2015; Berlin, GERMANY. [Poster]
FullText

 

Gattringer, T; Kneihsl, M; Enzinger, C; Wunsch, G; Khalil, M; Urbanic-Purkart, T; Payer, F; Niederkorn, K; Fazekas, F Poor short-term outcome in patients with ischemic stroke and active cancer
EUR J NEUROL. 2015; 22: 228-228.-1st Congress of the European-Academy-of-Neurology; JUN, 2015; Berlin, GERMANY. [Poster]
Web of Science

 

Jehna, M; Pirpamer, L; Khalil, M; Fuchs, S; Ropele, S; Langkammer, C; Pichler, A; Stulnig, F; Deutschmann, H; Fazekas, F; Enzinger, C Periventricular lesion burden in multiple sclerosis correlates with cortical thinning
MULT SCLER J. 2015; 21: 180-181.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN. Doi: 10.1177/135245851560 [Poster]
Web of Science FullText FullText_MUG

 

Jehna, M; Pirpamer, L; Khalil, M; Stulnig, F; Fuchs, S; Ropele, S; Langkammer, C; Pichler, A; Deutschmann, H; Fazekas, F; Enzinger, C Periventricular lesion burden in multiple sclerosis correlates with cortical thinning
EUR J NEUROL. 2015; 22: 155-155.-1st Congress of the European-Academy-of-Neurology; JUN, 2015; Berlin, GERMANY. [Poster]
Web of Science FullText

 

Khalil, M. Neues zu Biomarkern bei Multipler Sklerose - Liquor und Serum
Fortbildungsabend der Universitätsklinik für Neurologie; MAR 12, 2015; Graz, AUSTRIA. 2015. [Oral Communication]

 

Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Archelos, J-J; Fuchs, S; Seifert-Held, T; Fazekas, F. Cerebrospinal fluid lipocalin-2 levels are reduced in multiple sclerosis and correlate with putaminal iron accumulation
http://www.eaneurology.org/berlin2015/. 2015; -1st Congress of the European Academy of Neurology; June 20-23, 2015; Berlin, GERMANY. [Oral Communication]

 

Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Archelos, J-J; Fuchs, S; Seifert-Held, T; Fazekas, F. Cerebrospinal fluid lipocalin-2 levels are reduced in multiple sclerosis and correlate with putaminal iron accumulation.
Neurologisch, Supplementum 2/2015. 2015; 2015(2):23-23.-12. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 25-27; Graz, AUSTRIA. [Poster]

 

Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Archelos-Garcia, JJ; Fuchs, S; Seifert-Held, T; Fazekas, F Cerebrospinal fluid lipocalin-2 levels are reduced in multiple sclerosis and correlate with putaminal iron accumulation
EUR J NEUROL. 2015; 22: 87-87.-1st Congress of the European-Academy-of-Neurology; JUN, 2015; Berlin, GERMANY. [Poster]
Web of Science

 

Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Bachmaier, G; Archelos, JJ; Fuchs, S; Seifert-Held, T; Fazekas, F Impact of cerebrospinal fluid lipocalin-2 on brain iron accumulation and clinical progression in multiple sclerosis
MULT SCLER J. 2015; 21: 632-632.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN. [Poster]
Web of Science

 

Kneihsl, M; Enzinger, C; Wünsch, G; Khalil, M; Urbanic-Purkart, T; Payer, F; Niederkorn, K; Fazekas, F; Gattringer, T Koinzidenz von ischämischem Schlaganfall und maligner Grunderkrankung
12. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR 25-27, 2015; Graz, AUSTRIA. 2015. [Poster]

 

Stojakovic, T; Voortman, MM; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
Hematology Reports. 2015; 7(S1):67-67.-7th International Symposium on Clinical Applications of Free Light Chain and Heavy/Light Chain Analysis; APR 16-17, 2015; Edinburgh, UNITED KINGDOM. [Poster]

 

Voortman, M M; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, J-J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M. Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
12. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 25-27; Graz, AUSTRIA. 2015. [Poster]

 

Voortman, M; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos-Garcia, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
EUR J NEUROL. 2015; 22: 398-398.-1st Congress of the European Academy of Neurology (EAN); JUN, 2015; Berlin, GERMANY. [Poster]
Web of Science

 

Voortman, M.M; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, J.J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
Eur J Neurol. 2015; 22(S1):398-398.-1st Congress of the European Academy of Neurology (EAN); JUN 20-23, 2015; Berlin, GERMANY. [Poster]

 

Voortman, MM; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, J-J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Cerebrospinal fluid immunoglobulin free light chains as diagnostic and prognostic tool in clinically isolated syndrome and multiple sclerosis.
Inflame Symposium on Inflammation & Immunology; SEP 14-15, 2015; Graz, AUSTRIA. 2015. [Oral Communication]

 

Voortman, MM; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Increased cerebrospinal fluid immunoglobulin free light chain levels in relation to lesion load and cortical thinning of multiple sclerosis patients
MULT SCLER J. 2015; 21: 630-630.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN. [Poster]
Web of Science

 

Voortman, MM; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
Neurologisch, Supplementum 2/2015. 2015; 2: 25-25.-12. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 25-27, 2015; Graz, AUSTRIA. [Poster]

 

Voortman, MM; Stojakovic, T;Jehna, M;Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, J-J; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Increased cerebrospinal fluid immunoglobulin free light chain levels in relation to lesion load and cortical thinning of multiple sclerosis patients.
Multiple Sclerosis Journal. 2015; 21(S11):630-630.-31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); OCT 7-10, 2015; Barcelona, SPAIN. [Poster]
FullText

 

Walleczek, NK; Rauschka, H; Bsteh, G; Birkl, CB; Khalil, M; Fuchs, S; Enzinger, C; Fazekas, F; Eggers, C; Leutmezer, F; Salhofer-Polanyi, S; Baumgartner, A; Blechinger, S; Koppi, S; Sellner, J; Kraus, J; Assar, H; Gugger, M; Ehling, R; Moser, H; Raber, B; Liendl, H; Parigger, S; Mayr, M; Hiller, MS; Meister, B; Morgenstern, G; Spiess, HK; Kempf, I; Cisar, A; Bachler, H; Lehninger, R; Berger, T; Kristoferitsch, W; Aboulenein-Djamshidian, F Month-of-birth-effect in multiple sclerosis in Austria
MULT SCLER J. 2015; 21: 102-103.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN. [Poster]
Web of Science

 

Enzinger, C (presented on behalf of Khalil M); Khalil, M; Langkammer, C; Pichler, A; Pinter, D; Mader, A; Bachmaier, G; Ropele, S; Fuchs, S; Fazekas, F; Dynamics of brain iron accumulation differ between clinically isolated syndrome and multiple sclerosis: a longitudinal 3T MRI study.
EUR J NEUROLOGY. EUROPEAN JOURNAL OF NEUROLOGY21: 58-58. HOBOKEN: WILEY-BLACKWELL; ( Presented at: Joint Congress of European Neurology, Istanbul, TURKEY, MAY 31-JUN 03, 2014) [Oral Communication]
Web of Science

 

Hegen, H; Axtell, R; Hu, Y; Millonig, A; Bertolotto, A; Comabella, M; Giovanonni, G; Guger, M; Hoelzl, M; Khalil, M; Killestein, J; Lindberg, R; Malucchi, S; Mehling, M; Montalban, X; Rudzki, D; Schautzer, F; Sellebjerg, F; Sorensen, PS; Steinman, L; Deisenhammer, F Serum biomarkers predict IFNb treatment response in patients with multiple sclerosis
J NEUROL. 2014; 261: S43-S43.
Web of Science

 

Hegen, H; Axtell, R; Hu, Y; Millonig, A; Bertolotto, A; Comabella, M; Giovanonni, G; Guger, M; Hoelzl, M; Khalil, M; Killestein, J; Lindberg, R; Malucchi, S; Mehling, M; Montalban, X; Rudzki, D; Schautzer, F; Sellebjerg, F; Sorensen, PS; Steinman, L; Deisenhammer, F; Serum biomarkers predict IFNb treatment response in patients with multiple sclerosis.
EUR J NEUROLOGY. 2014; 21: 57-57.-Joint Congress of European Neurology; MAY 31-JUN 03, 2014; Istanbul, TURKEY. [Poster]
Web of Science

 

Jehna, M; Pirpamer, L; Khalil, M; Fazekas, F; Fuchs, S; Ropele, S; Langkammer, C; Pichler, A; Stulnig, F; Enzinger, C Kortikale Atrophie und periventrikuläre Läsionen bei Multipler Sklerose - idente Pathophysiologie?
14. Österreichisches fMRT Symposium (ÖGfMRT); Dec 13, 2014; Graz, AUSTRIA. 2014. [Oral Communication]

 

Khalil, M Monitoring bei MS - praktische klinische Anwendung - Monitoring anhand des Labors.
MS Akademie; SEP 26-27, 2014; Mondsee, AUSTRIA. 2014. [Oral Communication]

 

Khalil, M Biomarkers in MS.
Multiple Sclerosis Management 2014: Raising expectations; JUN 27-28, 2014; Vienna, AUSTRIA. 2014. [Oral Communication]

 

Khalil, M; Langkammer, C; Pichler, A; Pinter, D; Gattringer, T; Bachmaier, G; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F Dynamics of brain iron accumulation differ between clinically isolated syndrome and definite multiple sclerosis: a longitudinal 3T MRI study
Proceedings of the 2014 Joint ACTRIMS-ECTRIMS Meeting. 2014; -2014 JOINT ACTRIMS-ECTRIMS MEETING; SEPT 10-13, 2014; BOSTON, MA USA. [Poster]
FullText

 

Khalil, M; Langkammer, C; Pichler, A; Pinter, D; Gattringer, T; Bachmaier, G; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F Dynamics of brain iron accumulation differ between clinically isolated syndrome and definite multiple sclerosis: a longitudinal 3T MRI study
Multiple Sclerosis Journal - 2014 Joint Actrims-Ectrims Meeting (MS Boston 2014). 2014; 20(S1):269-269.-MS Boston 2014 - Joint ACTRIMS-ECTRIMS Meeting; SEP 10-13, 2014; Boston, USA. [Poster]
Web of Science FullText

 

Khalil, M; Langkammer, C; Pichler, A; Pinter, D; Mader, A; Bachmaier, G; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F Dynamics of brain iron accumulation differ between clinically isolated syndrome and multiple sclerosis: a longitudinal 3T MRI study
J NEUROL. 2014; 261: S43-S43.-Joint Congress of European Neurology; MAY 31-JUN 03, 2014; Istanbul, TURKEY. [Oral Communication]
Web of Science

 

Khalil, M; Renner, A; Langkammer, C; Enzinger, C;Ropele, S; Stojakovic, T; Scharnagl, H; Archelos, J-J; Fuchs, S; Seifert-Held, T; Fazekas, F Cerebrospinal fluid lipocalin-2 levels are reduced in multiple sclerosis and correlate with putaminal iron accumulation
NCA NUBIN 2014 Symposium - The 5th biannual symposium on body fluid biomarkers for inflammation and neurodegeneration.; October 29-30, 2014; Amsterdam, THE NETHERLANDS. 2014. [Oral Communication]

 

Pichler, A; Khalil, M; Langkammer, C; Bachmaier, G; Ropele, S; Fuchs, S; Pinter, D; Enzinger, C; Fazekas, F; . Longitudinal changes of global and compartmental brain atrophy in patients with clinically isolated syndrome and clinically definite multiple sclerosis using 3-Tesla Magnetic Resonance Imaging.
Jahrestagung der österreichischen Gesellschaft für Neurologie ; März 26-29, 2104; Salzburg. 2014. [Poster]

 

Pichler, A; Khalil, M; Langkammer, C; Mader, A; Bachmaier, G; Ropele, S; Fuchs, S; Pinter, D; Enzinger, C; Fazekas, F Longitudinal changes of global and compartmental brain atrophy in patients with clinically isolated syndrome and clinically definite multiple sclerosis using 3-Tesla magnetic resonance imaging
J NEUROL. 2014; 261: S44-S44.-Joint Congress of European Neurology; MAY 31-JUN 03, 2014; Istanbul, TURKEY. [Oral Communication]
Web of Science

 

Pichler, A; Khalil, M; Langkammer, C; Mader, A; Bachmaier, G; Ropele, S; Fuchs, S; Pinter, D; Enzinger, C; Fazekas, F; Longitudinal changes of global and compartmental brain atrophy in patients with clinically isolated syndrome and clinically definite multiple sclerosis using 3-Tesla magnetic resonance imaging.
EUR J NEUROLOGY. EUROPEAN JOURNAL OF NEUROLOGY21: 59-59. HOBOKEN: WILEY-BLACKWELL; ( Presented at: Joint Congress of European Neurology, Istanbul, TURKEY, MAY 31-JUN 03, 2014) [Oral Communication]
Web of Science

 

Pinter, D; Khalil, M; Pichler A; Langkammer, C; Fuchs, S; Fazekas, F; & Enzinger, C Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in Multiple Sclerosis.
11. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR, 26-29, 2014; Salzburg, AUSTRIA. 2014. [Poster]

 

Canto, E; Tintore, M; Costa, C; Arrambide, G; Villar, LM; Alvarez-Cermeno, JC; Deisenhammer, F; Hegen, H; Khademi, M; Olsson, T; Piehl, F; Bartos, A; Simova, D; Kotoucova, J; Kuhle, J; Kappos, L; Garcia-Merino, JA; Saiz, A; Blanco, Y; Hintzen, R; Jafari, N; Brassat, D; Tumani, H; Lauda, F; Roesler, R; Rejdak, K; Papuc, E; de Andres, C; Khalil, M; Galimberti, D; Scarpini, E; Montalban, X; Comabella, M Validation of cerebrospinal fluid chitinase 3-like 1 as a prognostic biomarker of conversion to multiple sclerosis and disease severity in patients with clinically isolated syndromes
MULT SCLER J. 2013; 19(11): 44-45. [Oral Communication]
Web of Science

 

Hegen, H; Millonig, A; Bertolotto, A; Comabella, M; Giovanonni, G; Guger, M; Hoelzl, M; Khalil, M; Killestein, J; Lindberg, R; Malucchi, S; Mehling, M; Montalban, X; Polman, C; Rudzki, D; Schautzer, F; Sellebjerg, F; Sorensen, PS; Deisenhammer, F Early detection of neutralizing antibodies to interferon beta in multiple sclerosis patients
MULT SCLER J. 2013; 19(11): 294-295. [Poster]
Web of Science

 

Khalil, M Krankheitsmonitoring bei MS: Monitoring anhand des Labors
Die MS-Akademie der ÖGN 2013; 13.-14.09.2013; Salzburg, Austria. 2013. [Oral Communication]

 

Khalil, M State-of-the-art and opinion on clinical applicability of biomarkers
Multiple Sclerosis Journal. 2013; --29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis; OCT 2-5, 2013; Copenhagen, DENMARK. [Oral Communication]

 

Khalil, M Cortical demyelination and correlation with cognitive decline in MS
Multiple Sclerosis Management 2013: A Changing Landscape; APR 26-27; Vienna. 2013. [Oral Communication]

 

Khalil, M; Riedlbauer, B; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Culea, V; Petzold, A; Archelos, A; Fuchs, S; Fazekas, F Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis
Journal of Neurological Sciences. 2013; -XXI World Congress od Neurology; SEP 21-26, 2013; Vienna, AUSTRIA. [Poster]

 

Khalil, M; Riedlbauer, B; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Culea, V; Petzold, A; Teunissen, C; Archelos, JJ; Fuchs, S; Fazekas, F Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis
MULT SCLER J. 2013; 19(11): 545-545. [Poster]
Web of Science

 

Khalil, M; Riedlbauer, B;Langkammer, C;Enzinger, C;Ropele, S; Stojakovic, T; Scharnagl, H; Culea, V; Petzold, A; Archelos, J.J; Fuchs, S; Fazekas, F Cerebrospinal fluid (CSF) transferrin levels are reduced in patients with early multiple sclerosis
Journal of Neurology. 2013; 260, Supplement 1: 39-40.-Twenty-Third Meeting of the European Neurologic Society; JUN 8-11, 2013; Barcelona, SPAIN. [Oral Communication]

 

Kuhle, J; Dobson, R; Bestwick, JP; Topping, J; Dalla Costa, G; Khademi, M; Sombekke, M; Killestein, J; Evdoshenko, E; Lazareva, N; Runia, T; Zbornikova, P; Horakova, D; D'Alfonso, S; Thouvenot, E; Moll, N; Hegen, H; Rauch, S; Khalil, M; Fuchs, S; Lindberg, RLP; Derfuss, T; Llufriu, S; Franciotta, D; Roesler, R; Lauda, F; Rajda, C; Drulovic, J; Menge, T; Kieseier, BC; Avsar, T; Marignier, R; Malmestrom, C; Myhr, KM; Wergeland, S; Annibali, V; Romano, S; Carra, A; Laroni, A; Frederiksen, JL; Larsson, HB; Uccelli, A; Martinez, AD; Salvetti, M; Torkildsen, O; Lycke, J; Confavreux, C; Rejdak, K; Bosca, I; Brassat, D; Scarpini, E; Fenoglio, C; Galimberti, D; Siva, A; Hartung, HP; Dujmovic, I; Vecsei, L; Tumani, H; Bergamaschi, R; Colombo, E; Villoslada, P; Saiz, A; Enzinger, C; Kappos, L; Deisenhammer, F; Alvarez-Cermeno, JC; Villar, L; Pelletier, J; Lehmann, S; Castelnovo, G; Barizzone, N; Leone, M; Havrdova, E; Trojano, M; Iaffaldano, P; Direnzo, V; Comabella, M; Tintore, M; Montalban, X; Hintzen, R; Lapin, S; Teunissen, C; Piehl, F; Olsson, T; Furlan, R; Martinelli, V; Comi, G; Ramagopalan, S; Giovannoni, G Multivariate clinically isolated syndrome (CIS) risk factor study: towards individual prognosis and treatment indication in CIS
MULT SCLER J. 2013; 19(11): 33-34. [Oral Communication]
Web of Science

 

Langkammer, C; Khalil, M; Enzinger, C; Pinter, D; Fuchs, S; Ropele, S; Fazekas, F R2* as a potential MRI measure for demyelination in MS lesions
Journal of Neurology. 2013; 260, Supplement 1: 49-50.-Twenty-Third Meeting of the European Neurologic Society; JUN 8-11; Barcelona, SPAIN. [Oral Communication]

 

Pinter, D; Sumowski, J; DeLuca, J; Fazekas, F; Pichler, A; Khalil, M; Langkammer, C; Fuchs, S; Enzinger, C Educational attainment moderates the effect of T2 lesion load and thalamic atrophy on cognition in multiple sclerosis
MULT SCLER J. 2013; 19(11): 437-438. [Poster]
Web of Science

 

Pinter, D; Sumowski, J; Pichler, A; Khalil, M; Langkammer, C; Fuchs, S; Deluca, J; Fazekas, F; Enzinger, C Educational attainment moderates the effect of t2 lesion load and atrophy on cognition in multiple sclerosis
Journal of Neurological Sciences. 2013; 333(1-2):-XXI World Congress od Neurology; SEP 21-26, 2013; Vienna, AUSTRIA. [Oral Communication]

 

Aboul-Enein, F; Rauschka, H; Mader,S; Künz, B; Lutterotti, A; Seifert, ; Khalil, M; Rommer, P; Leutmezer, F; Vass, K; Stepansky, R; Lang, W; Fertl, E; Schlager, T; Weiser, V; Koppi, S; Kraus, J; Assar, H; Eggers, C; Reisz, M; Komposch, M; Simschitz, P; Schnabl, P; Skrobal, A; Moser, A; Freimüller, M; Storch, MK; Reindl, M; Berger, T; Kristoferitsch, W Erste Ergebnisse der ersten epidemiologischen Erfassung von Neuromyelitis optica (NMO) Patienten in Österreich.
10. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR 14-17, 2012; Graz, AUSTRIA. 2012. [Poster]

 

Enzinger, C; Khalil, M The relationship between Gray Matter Pathology in MS and functional changes of the brain
Ten years of research on GM: from pathology to clinical assessment and interventions; MAR 15, 2012; Padova, ITALY. 2012. [Oral Communication]

 

Jehna, M; Langkammer, C; Khalil, M; Fuchs, S; Neuper, C; Ropele, S; Reishofer, G; Fazekas, F; Enzinger, C; Ebner, F Emotionswahrnehmung bei Multipler Sklerose – eine (f)MRT-Studie
20. Jahrestagung der Österreichischen Gesellschaft für Neuroradiologie (ÖGNR); NOV 22-24; Graz, AUSTRIA. 2012. [Oral Communication]

 

Jehna, M; Langkammer, C; Khalil, M; Fuchs, S; Reishofer, G; Fazekas, F; Ebner, F; Enzinger C Räumliche Beziehung zwischen Änderungen im regionalen kortikalen Volumen und der Integrität assoziierter Faserverbindungen bei Multipler Sklerose
12. Österreichisches fMRT Symposium (ÖGfMRT); Dec 7-8, 2012; Salzburg, AUSTRIA. 2012. [Oral Communication]

 

Khalil, M MRI and soluble biomarkers for neurodegeneration in MS
NUBIN Symposium 2012; JUN 14-15, 2012; Amsterdam, The Netherlands. 2012. [Oral Communication]
FullText

 

Khalil, M; Enzinger, C; Langkammer, C; Ropele, S; Mader, A; Archelos, JJ; Fuchs, S; Blankenstein, MA; Fazekas, F; Teunissen, CE. CSF neural cell adhesion molecule in relation to 3T MRI-metrics in early multiple sclerosis
10. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR 14-17, 2012; Graz, AUSTRIA. 2012. [Poster]

 

Khalil, M; Enzinger, C; Langkammer, C; Ropele, S; Mader, A; Wallner-Blazek, M; Bachmaier, G; Archelos, JJ; Fuchs, S; Blankenstein, MA; Fazekas, F; Teunissen, CE CSF neural cell adhesion molecule in relation to 3T MRI-metrics in early multiple sclerosis.
Proceedings. 2012; -28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis; OCT 10-13, 2012; Lyon, FRANCE. [Poster]

 

Langkammer, C; Liu, T; Khalil, M; Enzinger, C; Jehna, M; Fuchs, S; Fazekas, F; Wang, Y; Ropele, S Quantitative susceptibility mapping in multiple sclerosis
Proceedings. 2012; -28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); OCT 10-13, 2012; Lyon, FRANCE. [Poster]

 

Langkammer, C; Liu, T; Khalil, M; Enzinger, C; Jehna, M; Fuchs, S; Fazekas, F; Wang, Y; Ropele, S Quantitative susceptibility mapping in the basal ganglia of multiple sclerosis patients.
Proceedings of the 29th Annual Meeting ESMRMB. 2012; -29th Annual Meeting ESMRMB; OCT 4-6, 2012; Lisbon, Portugal. [Poster]

 

Mader, A; Khalil, M; Enzinger, C; Langkammer, C; Ropele, S; Archelos, JJ; Blankenstein, MA; Fuchs, S;Fazekas, F; Teunissen, CE. CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome
10. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR 14-17, 2012 ; Graz, AUSTRIA. 2012. [Poster]

 

Pichler, A; Enzinger, C; Fuchs, S; Plecko-Starting, B; Gruber-Sedlmayr, U; Linortner, P; Langkammer, C; Khalil, M; Ropele, S; Fazekas, F. Differences and similarities in the evolution of morphologic brain abnormalities between paediatric and adult-onset multiple sclerosis
10. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR 14-17, 2012 ; Graz, AUSTRIA. 2012. [Poster]

 

Ropele, S; Wattjes, M; Kilsdonk, I; de Graaf, W; Langkamer, C; Frederiksen, J; Fuglo, D; Ciccarelli, O; Khalil, M; Rocca, M; Sprenger , T; KAppos, L; Filippi, M; Rovira, A; Miller, D; Barkhof, F; Fazekas , F R2* based iron mapping in multiple sclerosis: a multicentre study.
International Multiple Sclerosis Journal. 2012; -28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); OCT 10-13, 2012; Lyon, FRANCE. [Poster]

 

Enzinger, C; Fuchs, S; Pichler,A; Wallner-Blazek, M; Khalil, M; Langkammer, C; Ropele, S; Fazekas, F Predicting the severity of relapsing-remitting MS: The contribution of cross-sectional and short-term follow-up MRI data
NeuroLogisch2011; Supplement(März):-9. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR 16-19, 2011 ; Vienna, AUSTRIA. [Oral Communication]

 

Jehna, M; Langkammer, C; Wallner-Blazek, M; Neuper, C; Loitfelder, M; Fuchs, S; Khalil, M; Fazekas, F; Enzinger, C Cognitively preserved MS patients demonstrate functional differences in processing neutral and emotional faces
11. Neuroscience Wintermeeting; MAR 31 - APR 2, 2011; Kitzbühel, AUSTRIA. 2011. [Oral Communication]

 

Jehna, M; Langkammer, C; Wallner-Blazek, M; Neuper, C; Loitfelder, M; Fuchs, S; Khalil, M; Fazekas, F; Enzinger, C Cognitively preserved MS patients demonstrate functional differences in processing neutral and emotional faces
J NEUROL. 2011; 258: 154-154. [Poster]
Web of Science

 

Jehna, M; Langkammer, C; Wallner-Blazek, M; Neuper, C; Loitfelder, M; Ropele, S; Fuchs, S; Khalil, M; Fazekas, F; Enzinger, C Cognitively preserved MS patients demonstrate functional differences in processing neutral and emotional faces
NeuoLogisch2011; -9. Jahrestagung der Oesterreichischen Gesellschaft für Neurologie (ÖGN); MAR 16-19, 2011; Vienna, AUSTRIA. [Oral Communication]

 

Khalil, M CSF markers for axonal damage in relation to quantitative MRI-metrics in multiple sclerosis
NUBIN (NeuroUnit Biomarkers for Inflammation and Neurodegeneration) meeting ; FEB 15, 2011 ; VU University Medical Center, Amsterdam, THE NETHERLANDS. 2011. [Oral Communication]

 

Khalil, M; Enzinger, C; Langkammer, C; Ropele, S; Mader, A; Vane, M; Trentini, A; Wallner-Blazek, M; Archelos, JJ; Blankenstein, MA; Fuchs, S; Fazekas, F; Teunissen, CE CSF neurofilaments and N-acetylaspartate in relation to MRI-metrics at 3T in clinically isolated syndromes suggestive of multiple sclerosis
Multiple Sclerosis Journal (Formerly Multiple Sclerosis). 2011; 17(S10):S266--5th Joint Triennial Congress of ECTRIMS and ACTRIMS; OCT 19–22, 2011 ; Amsterdam, The NETHERLANDS. [Poster]

 

Langkammer, C; Khalil, M; Wallner-Blazek, M; Enzinger, C; Fuchs S; Fazekas, F; Ropele, S Quantitative assessment of iron accumulation in multiple sclerosis
Proceedings of the ISMRM 19th Scientific Meeting & Exhibition2011; -ISMRM 19th Scientific Meeting & Exhibition; MAY 6-13, 2011; Montreal, Canada. [Oral Communication]

 

Enzinger, C; Fazekas, F; Vecsei, L; Jenkinson, M; Ropele, S; Khalil, M; Petrovic, K; Loitfelder, M; Langkammer, C; Aspeck, E; Wallner-Blazek, M; Fuchs, S; Jehna, M; Kincses, T Neurological deficits, cognitive performance, and white matter lesion location in multiple sclerosis.
Multiple Sclerosis2010; 16 (Suppl.)(10):S115-S115.-26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); OCT 13-16, 2010; Göteborg, SCHWEDEN. [Poster]

 

Enzinger, C; Pichler, A; Fuchs, S; Wallner-Blazek, M; Khalil, M; Langkammer, C; Ropele, S; Fazekas, F Predicting the severity of relapsing-remitting MS: the contribution of cross-sectional and short-term follow-up MRI data.
Multiple Sclerosis2010; 16 (Suppl.)(10):S260-S260.-26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); OCT 13-16, 2010; Gothenburg, SCHWEDEN. [Poster]

 

Fazekas, C; Khalil, M; Enzinger, C; Fuchs, S; Fazekas, F Attachment style and temperament in people with early stages of multiple sclerosis
J PSYCHOSOM RES. 2010; 68(6): 47 [Poster]
Web of Science

 

Jehna, M; Langkammer, C; Wallner-Blazek, M; Neuper, C; Loitfelder, M; Ropele, S; Ebner, F; Fuchs, S; Khalil, M; Fazekas, F; Enzinger, C Altered network activation during perception of faces in MS and their relationship to brain tissue changes.
Multiple Sclerosis2010; 16 (Suppl.)(10):S109-S109.-26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) & 15th Annual Conference of Rehabilitation in MS (RIMS); OCT 13-16, 2010; Gothenburg, SWEDEN. [Poster]

 

Jehna, M; Langkammer, C; Wallner-Blazek, M; Neuper, C; Loitfelder, M; Ropele, S; Ebner, F; Fuchs, S; Khalil, M; Fazekas, F; Enzinger, C Emotionswahrnehmung bei Multipler Sklerose – eine fMRT-Studie
INGE St. Kongress; OCT 7, 2010; Graz, AUSTRIA. 2010. [Poster]

 

Jehna, M; Neuper, M; Loitfelder, M; Fuchs, S; Ischebeck, A; Wallner-Blazek, M; Khalil, M; Ropele, S; Fazekas, F; Enzinger, C FMRI correlates of emotional perception in healthy subjects and patients with Multiple Sclerosis - insights from an ongoing study
8. JAHRESTAGUNG DER ÖSTERREICHISCHEN GESELLSCHAFT FÜR NEUROLOGIE; FEB 24-27, 2010; Linz, AUSTRIA. 2010. [Poster]

 

Jehna, M; Wallner-Blazek, M; Khalil, M; Loitfelder, M; Fuchs, S; Ischebeck, A; Ropele, S; Neuper, C; Fazekas, F; Enzinger, C FMRI correlates of neutral and emotional facial recognition in Multiple Sclerosis
16th Annual Meeting of the Organization for Human Brain Mapping; June 6-10, 2010; Barcelona, Spain. 2010. [Poster]

 

Khalil, M Biomarkers for axonal damage and neurodegeneration in MS
NUBIN (NeuroUnit Biomarkers for Inflammation and Neurodegeneration) meeting ; MAR 15, 2010; VU University Medical Center, Amsterdam, THE NETHERLANDS. 2010. [Oral Communication]

 

Khalil, M; Enzinger, C; Langkammer, C; Petrovic, K; Loitfelder, M; Tscherner, M; Jehna, M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F Cognitive impairment in patients with a clinically isolated syndrome – correlation with MRI parameters including magnetization transfer imaging
8. JAHRESTAGUNG DER ÖSTERREICHISCHEN GESELLSCHAFT FÜR NEUROLOGIE; FEB 24-27, 2010; Linz, AUSTRIA. 2010. [Poster]

 

Khalil, M; Koel-Simmelink, M; Jimenez, CR; Blankenstein, M.A.; Teunissen, C Validation of serum complement III factor fragment as a biomarker for disease progression in multiple sclerosis
MS RESEARCH DAYS 2010; DEC 14-15, 2010; ALPHEN AAN DEN RIJN, THE NETHERLANDS. 2010. [Poster]

 

Khalil, M; Langkammer, C; Ropele, S; Petrovic, K; Loitfelder, M; Jehna, M; Tscherner, M; Wallner-Blazek, M; Schmidt, R; Enzinger, C; Fuchs, S; Fazekas, F Increased brain iron levels by R2* relaxometry in relation to cognitive deficits in multiple sclerosis.
Mult Scler2010; 16 (Suppl.)(10):S98-S99.-26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) & 15th Annual Conference of Rehabilitation in MS (RIMS); OCT 13-16, 2010 ; Gothenburg, SWEDEN. [Poster]

 

Langkammer, C; Khalil, M; Ropele, S; Wallner-Blazek, M; Enzinger, C; Fuchs S; Fazekas, F Quantitative assessment of iron accumulation in multiple sclerosis lesions using R2* relaxometry.
Multiple Sclerosis2010; 16 (Suppl.)(10):S266-S266.-26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) & 15th Annual Conference of Rehabilitation in MS (RIMS); OCT 13-16, 2010; Gothenburg, SWEDEN. [Poster]

 

Schmied, M; Zehetmayer, S; Bajer-Kornek, B; Hotzy, C; Zebenholzer, K; Leutmezer, F; Kristoferitsch, W; Reindl, M; Khalil, M; Fuchs, S; Schmidt, H; Fazekas, F; Berger, T; Vass, K; Zimprich; A Assoziationsanalyse von Kandidatenloci für Multiple Sklerose
8. JAHRESTAGUNG DER ÖSTERREICHISCHEN GESELLSCHAFT FÜR NEUROLOGIE; FEB 24-27, 2010; Linz, AUSTRIA. 2010. [Poster]

 

Wallner-Blazek, M; Khalil, M; Petrovic, K; Hochmeister, S; Seifert-Held, T; Enzinger, C; Storch, M; Schmidt, R; Fazekas, F; Fuchs, S Klassifikation und Prognose der Multiplen Sklerose und verwandter Krankheitsbilder.
MUG-Forschungsfeld Neurowissenschaften; JUN 10, 2010; Graz, AUSTRIA. 2010. [Oral Communication]

 

Khalil, M Neuroimmunolgie und Immuntherapie: Humorale Apsekte
Facharztausbildungsseminar der Österreichischen Gesellschft für Neurologie ; NOV 5-7, 2009; Graz, AUSTRIA. 2009. [Oral Communication]

 

Khalil, M Susceptibility weighted imaging and iron mapping in MS: Iron deposition and its clinical correlations
MAGNIMS Meeting Graz ; Nov 19-20, 2009; Graz, AUSTRIA. 2009. [Oral Communication]

 

Khalil, M Multiple Sklerose: Allgemeines, Diagnostik und Therapie
ÖZIV Support; NOV 4, 2009; Spital am Phyrn. 2009. [Oral Communication]

 

Khalil, M Neuroimmunologie und Immuntherapie: Immunneuropathien
Facharztausbildungsseminar der Österreichischen Gesellschaft für Neurologie; NOV 5-7, 2009; Graz, AUSTRIA. 2009. [Oral Communication]

 

Khalil, M Klinische Liquordiagnostik 2009: Liquordiagnostik bei Multipler Sklerose, NMO, PML
Klinische Liquordiagnostik 2009; NOV 20, 2009; Graz, AUSTRIA. 2009. [Oral Communication]

 

Khalil, M; Enzinger, C; Langkammer, C; Petrovic, K; Loitelder, M; Tscherner, M; Jehna, M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F The Spectrum of Cognitive Impairment and Its Relation to Brain Morphology Including Iron Deposition in Multiple Sclerosis.
NEUROLOGY. 2009; 72(11):A142-A142.-61st Annual Meeting of the American Academy of Neurology (AAN); APR 25-May 2, 2009; Seattle, USA. [Poster]
Web of Science

 

Khalil, M; Enzinger, C; Langkammer, C; Petrovic, K; Loitfelder, M; Tscherner, M; Jehna, M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F The Spectrum of Cognitive Impairment and its relation to Brain Morphology including Iron Deposition in Multiple Sclerosis
neurologisch2009; Sonderausgabe: 14-15.-7. Jahrestagung der Österreichischen Gesellschaft für Neurologie und Jahrestagung der Österreichischen Gesellschaft für Neurorehabilitation; MAR 25-28, 2009; Villach, AUSTRIA. [Poster]

 

Khalil, M; Enzinger, C; Langkammer, C; Petrovic, K; Loitfelder, M; Tscherner, M; Jehna, M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F Cognitive impairment in patients with a clinically isolated syndrome - correlation with MRI parameters including magnetization transfer imaging.
MULT SCLER. 2009; 15(9):S227-S228.-25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); SEP 9–12, 2009; Düsseldorf, GERMANY. [Poster]
Web of Science

 

Khalil, M; Enzinger, C; Langkammer, C; Petrovic, K; Loitfelder, M; Tscherner, M; Jehna, M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F The Spectrum of Cognitive Impairment and its relation to Brain Morphology including Iron Deposition in Multiple Sclerosis
neurologisch2009; Sonderausgabe: 23-23.-10. Austrian Neuroscience Wintermeeting; MAR 4-7, 2009; Kitzbühel, AUSTRIA. [Poster]

 

Khalil, M; Enzinger, C; Langkammer, C; Tscherner, M; Wallner-Blazek, M; Jehna, M; Ropele, S; Fuchs, S; Fazekas, F Quantitative assessment of brain iron by R2* relaxometry in patients with clinically isolated syndrome and relapsing remitting multiple sclerosis
neurologisch2009; Sonderausgabe: 14-14.-7. Jahrestagung der Österreichischen Gesellschaft für Neurologie und Jahrestagung der Österreichischen Gesellschaft für Neurorehabilitation; MAR 25-28, 2009; Villach, AUSTRIA. [Poster]

 

Khalil, M; Enzinger, C; Langkammer, C; Tscherner, M; Wallner-Blazek, M; Jehna, M; Ropele, S; Fuchs, S; Fazekas, F Quantitative Assessment of Brain Iron by R2(star) Relaxometry in Patients with Clinically Isolated Syndrome or Relapsing Remitting Multiple Sclerosis.
NEUROLOGY. 2009; 72(11):A435-A435.-61st Annual Meeting of the American Academy of Neurology (AAN); APR 25-May 2 2009; Seattle, USA. [Oral Communication]
Web of Science

 

Khalil, M; Enzinger, C; Langkammer, C; Tscherner, M; Wallner-Blazek, M; Jehna, M; Ropele, S; Fuchs, S; Fazekas, F Quantitative assessment of brain iron by R2* relaxometry in patients with clinically isolated syndrome and relapsing remitting multiple sclerosis.
Neurology 72 March 17, 2009 (Suppl 3)2009; Suppl. Volume 72(11):435-435.-American Academy of Neurology 61st Annual Meeting, April 25 to May 2, 2009; APR. 25 to MAY 02, 2009; Seattle, USA. [Oral Communication]

 

Khalil, M; Enzinger, C; Langkammer, C; Tscherner, M; Wallner-Blazek, M; Jehna, M; Ropele, S; Fuchs, S; Fazekas, F Quantitative assessment of brain iron by R2* relaxometry in patients with clinically isolated syndrome and relapsing remitting multiple sclerosis
neurologisch2009; Sonderausgabe: 22-22.-10. Austrian Neuroscience Wintermeeting; MAR 4-7, 2009; Kitzbühel, AUSTRIA. [Poster]

 

Khalil, M; Enzinger, C; Petrovic, K; Loitfelder, M; Tscherner, M; Jehna. M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F Executive dysfunction represents an underestimated component of cognitive impairment in multiple sclerosis.
Multiple Sclerosis2008; 14(S1):S258-S259.-World Congress on Treatment and Research in Multiple Sclerosis: ACTRIMS + ECTRIMS + LACTRIMS; SEPT 17-20, 2008; Montreal, CANADA. [Poster]
Web of Science

 

Khalil, M; Enzinger, C; Petrovic, K; Loitfelder, M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F Spectrum of cognitive impairment including higher executive functions in patients with multiple sclerosis
6. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); FEB 6-9, 2008; Innsbruck, AUSTRIA. 2008. [Poster]

 

Khalil, M; Enzinger, C; Wallner-Blazek, M; Scarpatetti, M; Barth, A; Horn, S; Reiter, G EBV-encephalitis presenting with a tumor-like lesion in a kidney and pancreas transplant immunosuppressed recipient
6. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); FEB 6-9, 2008; Innsbruck, AUSTRIA. 2008. [Poster]

 

Wallner-Blazek, M; Enzinger C, Petrovic K, Loitfelder M, Tscherner M, Jehna M, Khalil M, Ropele S, Schmidt R, Fuchs S, Fazekas F Spectrum of cognitive impairment including higher executive functions in patients with Multiple Sclerosis
52.wissenschaftliche Jahrestagung der deutschen Gesellschaft für klinische Neurophysiologie und funktionelle Bildgebung; 10.-12.4.2008; Magdeburg,Germany. 2008. [Poster]

 

Khalil, M Humorale Aspekte der MS.
Facharztausbildungsseminar der Österreichischen Gesellschaft für Neurologie; 02.-04. April 2006; Graz, Austria. 2006. [Oral Communication]

 

Khalil, M Monoklonale Antikörper.
Facharztausbildungsseminar der Österreichischen Gesellschaft für Neurologie; 02.-04. April 2006; Graz, Austria. 2006. [Oral Communication]

 

Khalil, M; Kuenz, B; Lutterotti, A; Ehling, R; Gneiss, C; Egg, R; Mayringer, I; Deisenhammer, F; Reindl, M; Berger, T Levels of serum IgM antibody against native MOG predict responsiveness to corticosteroids for treatment of acute multiple sclerosis relapses
4. Jahrestagung der österreichischen Gesellschaft für Neurologie; 15.–18. März 2006; Vienna, Austria. 2006. [Oral Communication]

 

Khalil, M; Kuenz, B; Lutterotti, A; Ehling, R; Gneiss, C; Egg, R; Mayringer, I; Deisenhammer, F; Reindl, M; Berger, T Levels of serum IgM antibody against refolded recombinant human MOG predict responsiveness to corticosteroids for treatment of acute multiple sclerosis relapses
J NEUROIMMUNOL. 2006; 178: 202-202. [Poster]
Web of Science

 

Khalil, M; Zehrer, V; Egg, R; Lutterotti, A; Ehling, R; Gneiss, C; Mayringer, I; Kuenz, B; Reindl, M; Deisenhammer, F; Berger, T Interferon-beta in multiple sclerosis: ten years' experience in a multiple sclerosis specialist centre
MULT SCLER. 2006; 12: S195-S195. [Poster]
Web of Science

 

Khalil, M; Zehrer, V; Egg, R; Lutterotti, A; Ehling, R; Mayringer, I; Gneiss, C; Kuenz, B; Deisenhammer, F; Reindl, M; Berger, T 10 years interferon beta therapy in a multiple sclerosis specialist center
4. Jahrestagung der österreichischen Gesellschaft für Neurologie; 15.–18. März 2006; Vienna, Austria. 2006. [Poster]

 

Kuenz, B; Lutterotti, A; Ehling, R; Gneiss, C; Khalil, M; Deisenhammer, F; Berger, T; Reindl, M Characterization of cell populations in cerebrospinal fluid of patients with multiple sclerosis
Multiple Sclerosis. 12(suppl 1): 64--ECTRIMS; 28. - 30. September 2006; Madrid, Spain. [Poster]

 

Kuenz, B; Lutterotti, A; Ehling, R; Gneiss, C; Khalil, M; Deisenhammer, F; Berger, T; Reindl, M Characterisation of cell populations in cerebrospinal fluid of patients with multiple sclerosis
MULT SCLER. 2006; 12: S64-S64. [Poster]
Web of Science

 

Kuenz, B; Lutterotti, A; Ehling, R; Gneiss, C; Khalil, M; Deisenhammer, F; Berger, T; Reindl, M Characterization of cell populations in cerebrospinal fluid of patients with multiple sclerosis
4. Jahrestagung der österreichischen Gesellschaft für Neurologie; 15.–18. März 2006; Vienna, Austria. 2006. [Poster]

 

Lutterotti, A; Kuenz, B; Khalil, M; Gredler, V; Ehling, R; Gneiss, C; Deisenhammer, F; Berger, T; Reindl, M Serum levels of soluble CD14 correlate with disease activity in multiple sclerosis patients and are increased by interferon-beta treatment
MULT SCLER. 2006; 12: S66-S66. [Poster]
Web of Science

 

Gneiss, C; Brugger, M; Reindl, M; Berger, T; Ehling, R; Lutterotti, A; Khalil, M; Kunz, B; Mayringer, I; Deisenhammer, F Comparative study of four different assays for the detection of binding antibodies against interferon-beta
MULT SCLER. 2005; 11: S159-S160.
Web of Science

 

Khalil, M Clinical and immunological characterization of antimyelin antibodies in multiple sclerosis.
9th Meeting of the AUSTRIAN NEUROSCIENCE ASSOCIATION; 23.-26.June 2005; Obergurgl, Austria. 2005. [Oral Communication]

 

Khalil, M; Egg, R; Reindl, M; Lutterotti, A; Ehling, R; Gneiss, C; Kuenz, B; Deisenhammer, F; Berger, T Influence of immunomodulatory therapies on anti-myelin-antibodies in multiple sclerosis (MS)
J NEUROL SCI. 2005; 238: S225-S225.
Web of Science

 

Khalil, M; Harrasser, M; Lutterotti, A; Ehling, R; Gneiss, C; Künz, B; Deisenhammer, F; Reindl, M; Berger, T The ability of anti MOG antibodies to fix the terminal complement complex (TCC) differs among multiple sclerosis (MS) patients with different disease courses
3. Jahrestagung der österreichischen Gesellschaft für Neurologie; 1.–23. April 2005; Graz, Austria. 2005. [Oral Communication]

 

Khalil, M; Reindl, M; Lutterotti, A; Ehling, R; Gneiss, C; Kunz, B; Deisenhammer, F; Berger, T Impact of acute relapses and high-dose methylprednisolone therapy on serum anti-MOG antibodies in relapsing-remitting MS patients
MULT SCLER. 2005; 11: S169-S169.
Web of Science

 

Khalil, M; Reindl, M; Lutterotti, A; Ehling, R; Gneiss, C; Künz, B; Deisenhammer, F; Berger, T Impact of acute relapses and high-dose methylprednisolone therapy on serum anti MOG antibodies in relapsing remitting multiple sclerosis patients
3. Jahrestagung der österreichischen Gesellschaft für Neurologie; 21.–23. April 2005; Graz, Austria. 2005. [Poster]

 

Khalil, M; Reindl, M; Lutterotti, A; Ehling, R; Gneiss, C; Künz, B; Lackner, P; Deisenhammer, F; Berger, T Epitope specificity of antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein (MOG-Ig) during immunomodulatory therapies in multiple sclerosis patients
3. Jahrestagung der österreichischen Gesellschaft für Neurologie; 21.–23. April 2005; Graz, Austria. 2005. [Poster]

 

Khalil, M; Reindl, M; Lutterotti, A; Ehling, R; Gneiss, C; Künz, B; Lackner, P; Deisenhammer, F; Berger, T Epitope specificity of antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein (MOG-Ig) during immunomodulatory therapies in multiple sclerosis patients.
Myelin structure and its role in autoimmunity II; 1.-5. May 2005; Potenza, Italy. 2005. [Oral Communication]

 

Khalil, M; Reindl, M; Lutterotti, A; Ehling, R; Kuenz, B; Gneiss, C; Lackner, P; Berger, T Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein in multiple sclerosis.
Annual Meeting of the Austrian Society for Allergology and Immunology; 01.-03. Dec 2005; Graz, Austria. 2005. [Oral Communication]

 

Kuenz, B; Lutterotti, A; Ehling, E; Gneiss, C; Khalil, M; Berger, T; Reindl, M Characterization of cell populations in cerebrospinal fluid of patients with multiple scleros.
Annual Meeting of the Austrian Society for Allergology and Immunology; 01.-03. Dec 2005; Graz, Austria. 2005. [Oral Communication]

 

Kunz, B; Lutterotti, A; Ehling, R; Khalil, M; Reindl, M; Berger, T Increased plasma levels of soluble adhesion molecules sE-selectin, sPECAM-1 and sP-selectin are associated with relapsing-remitting disease course of multiple sclerosis
MULT SCLER. 2005; 11: S128-S128.
Web of Science

 

Künz, B; Lutterotti, A; Ehling, R; Khalil, M; Reindl, M; Berger, T Increased plasma levels of soluble adhesion molecules sE-selectin, sPECAM and sP-selectin are associated with relapsing-remitting disease course of multiple sclerosis.
3. Jahrestagung der österreichischen Gesellschaft für Neurologie; 21.–23. April 2005; Graz, Austria. 2005. [Poster]

 

Künz, B; Lutterotti, A; Khalil, M; Ehling, R; Reindl, M; Berger, T Increased plasmalevels of soluble adhesion molecules sE-selectin, sPECAM-1, sP-selectin are associated with relapsing-remitting disease course of multiple sclerosis.
9th Meeting of the AUSTRIAN NEUROSCIENCE ASSOCIATION; 23.-26. June 2005; Obergurgl, Austria. 2005. [Poster]

 

Lutterotti, A; Kuenz, B; Khalil, M; Ehling, R; Gneiss, C; Berger, T; Reindl, M Soluble CD14 serum levels in multiple sclerosis patients.
Annual Meeting of the Austrian Society for Allergology and Immunology; 01.-03. Dec 2005; Graz, Austria. 2005. [Poster]

 

Khalil, M; Harrasser, M; Lutterotti, A; Ehling, R; Gneiss, C; Deisenhammer, F; Reindl, M; Berger, T The ability of anti MOG antibodies to fix the terminal complement complex differs among multiple sclerosis patients with different disease courses
MULT SCLER. 2004; 10(7032): S104-S104.
Web of Science

 

Khalil, M; Reindl, M; Egg, R; Lutterotti, A; Ehling, R; Gneiss, C; Deisenhammer, E; Berger, T Influence of immunomodulatory therapies on anti-myelin antibodies in multiple sclerosis
MULT SCLER. 2004; 10(7032):S211-S212. [Poster]
Web of Science

 

Khalil, M; Reindl, M; Egg, R; Lutterotti, A; Ehling, R; Gneiss, C; Lackner, P; Deisenhammer, F; Berger, T Anti MOG and anti MBP antibodies in multiple sclerosis patients during interferon beta and glatiramer acetate therapy
2. Jahrestagung der österreichischen Gesellschaft für Neurologie; 18.-20. März 2004; Linz, Austria. 2004. [Poster]

 

Khalil, M; Reindl, M; Lutterotti, A; Ehling, R; Gneiss, C; Deisenhammer, F; Berger, T Epitope specificity of antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein (MOG-1g) during immunomodulatory therapies in multiple sclerosis patients
MULT SCLER. 2004; 10(7032): S165-S165.
Web of Science

 

Lutterotti, A; Ehling, R; Lassmann, H; Khalil, M; Gneiss, C; Gassner, C; Deisenhammer, F; Berger, T; Reindl, M The CD14 C(-260)T promoter polymorphism influences disease severity in multiple sclerosis patients
MULT SCLER. 2004; 10(7032): S208-S208.
Web of Science

 

Khalil, M; Reindl, M; Lutterotti, A; Egg, R; Schanda, K; Deisenhammer, F; Berger, T Anti MOG and anti MBP antibody subclasses in MS patients during INF-ß therapy
Multiple Sclerosis. 8(suppl 1): 123--ECTRIMS, Baltimore, 18. –21. September 2002; 18. –21. September 2002; Baltimore, USA. [Poster]

 

↑ Top of page / Navigation

© Med Uni Graz • Imprint